Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P2.06 - Mesothelioma (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.06-01 - Short-Term Outcome of Entire Pleural Intensity-Modulated Radiotherapy in a Neoadjuvant Setting for Malignant Mesothelioma
16:45 - 18:00 | Presenter: Ji Hyun Hong | Author(s): Yeon Sil Kim, Seung Joon Kim, Sook-Hee Hong, Kyung Soo Kim, Seok Whan Moon
- Abstract
Loading... -
+
P2.06-02 - Feasibility of Intensity Modulated Radiotherapy After Pleurectomy/Decortication for Malignant Pleural Mesothelioma Patients
16:45 - 18:00 | Presenter: Oscar Arrieta | Author(s): Francisco Lozano, Monica Blake, Zyanya Lucia Zatarain-Barrón, Laura-Alejandra Ramírez-Tirado, Miguel Angel Salinas Padilla, Federico Maldonado, Jose Francisco Corona-Cruz
- Abstract
Loading... -
+
P2.06-03 - Can We Predict Pathological Nodal Positivity in Malignant Pleural Mesothelioma from Preoperative Clinical Variables?
16:45 - 18:00 | Presenter: Silviu I Buderi | Author(s): Joanne Hargrave, Mariano Di Martino, Kelvin Lau, David Waller
- Abstract
Loading... -
+
P2.06-04 - Throughput of a Specialist Mesothelioma Multidisciplinary Team Meeting at a Radical Treatment Centre in the United Kingdom.
16:45 - 18:00 | Presenter: Edward J Caruana | Author(s): Alan George Dawson, Sridhar Rathinam, Apostolos Nakas
- Abstract
Loading... -
+
P2.06-05 - TTFields Applied to the Torso and Upper Abdomen: Safety Meta-Analysis of 176 Patients from four Phase I-II Trials
16:45 - 18:00 | Presenter: Giovanni L Ceresoli | Author(s): Miklos Pless, Manuel Benavides, Ignace Vergote
- Abstract
Loading... -
+
P2.06-06 - Role of GITRL-GITR System in Promoting Proliferation of Malignant Mesothelioma
16:45 - 18:00 | Presenter: Mei-Lin Chan | Author(s): Licun Wu, Zhihong Yun, Yidan Zhao, Mikihiro Kohno, Marc De Perrot
- Abstract
Loading... -
+
P2.06-07 - Genomic Deletion of BAP1 and CDKN2A are Better MM Diagnostic Biomarkers.
16:45 - 18:00 | Presenter: Yuen Yee Cheng | Author(s): Kadir Harun Sarun, Kenneth Lee, Candice Julie Clarke, Ngan Cheng, Ken Takahashi
- Abstract
Loading... -
+
P2.06-08 - ABT-806 Derived Antibody Drug Conjugates (ADCs) Inhibit Growth of Malignant Mesothelioma In-Vivo
16:45 - 18:00 | Presenter: Puey Ling Chia | Author(s): Diana Cao, Hui Gan, Angela Rigopoulos, Ed Riley, Andrew Phillips, Thomas John, Andrew Scott
- Abstract
Loading... -
+
P2.06-09 - MiST3: A Phase II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Pembrolizumab in pts with Malignant Mesothelioma
16:45 - 18:00 | Presenter: Dean A Fennell | Author(s): Matthew G Krebs, Louise Carter, Shaun Villa, Amy King, Clare Massey, James Lorens, Emma Darlington
- Abstract
Loading... -
+
P2.06-10 - Combination Chemotherapy with Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress
16:45 - 18:00 | Presenter: Nobukazu Fujimoto | Author(s): Keisuke Aoe, Toshiyuki Kozuki, Isao Oze, Katsuya Kato, Takumi Kishimoto, Katsuyuki Hotta
- Abstract
Loading... -
+
P2.06-11 - A Phase I/II Study of Intrapleural Ad-SGE-REIC Administration in Patients with Refractory Malignant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Yasushi Goto | Author(s): Yuichiro Ohe, Kozo Kuribayashi, Takashi Nakano, Morihito Okada, Shinichi Toyooka, Hiromi Kumon, Yoichi Nakanishi
- Abstract
Loading... -
+
P2.06-12 - Improving Quality of Care for Pleural Mesothelioma: 2018 National Mesothelioma Audit Results for England and Wales
16:45 - 18:00 | Presenter: Susan V Harden | Author(s): Aamir Khakwani, Paul Beckett
- Abstract
Loading... -
+
P2.06-13 - Poor Nutritional Status Is a Poor Prognostic Factor in Malignant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Walter Weder | Author(s): Masaki Hashimoto, Martina Friess, Olivia Lauk, Isabelle Opitz
- Abstract
Loading... -
+
P2.06-14 - Does Size Matter? A Population-Based Analysis of Malignant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Jiaxi He | Author(s): Jianfei Shen, Hui Pan
- Abstract
Loading... -
+
P2.06-15 - Malignant Pleural Mesothelioma in Young Adult People in Uganda
16:45 - 18:00 | Presenter: Nehemiya Igulu Bandese
- Abstract
Loading... -
+
P2.06-16 - YB-1: An Important Driver of Mesothelioma Drug Resistance and a Potential Novel Therapeutic Target
16:45 - 18:00 | Presenter: Karin Schelch | Author(s): Thomas George Johnson, Kadir Harun Sarun, Marissa Williams, Yuen Yee Cheng, Annette Lasham, Glen Reid
- Abstract
Loading... -
+
P2.06-17 - Real-World Accuracy of Malignant Pleural Mesothelioma (MPM) Preoperative Magnetic Resonance Imaging (MRI) for Staging the Diaphragm.
16:45 - 18:00 | Presenter: Sharyn Katz | Author(s): Stephanie Wu, Sally McNulty, Keith Cengel, Evan Alley, Sunil Singhal
- Abstract
Loading... -
+
P2.06-18 - Comparison of Extubation Time of Pleulectomy/Decortication with Lobectomy Under General Anesthesia Using Desflurane
16:45 - 18:00 | Presenter: Keisuke Kawata | Author(s): Naohiko Funatsu, Hiroyuki Tao, Kazumichi Okabe
- Abstract
Loading... -
+
P2.06-19 - Targeting Polyamines as Potential Adjuvant Therapy in Malignant Pleural Mesothelioma Xenograft Models
16:45 - 18:00 | Presenter: Sze Kwan Lam | Author(s): Sheng Yan, Shi Xu, James Chung-man Ho
- Abstract
Loading... -
+
P2.06-21 - Low Intratumoral Platinum Concentration is Associated with Unfavorable Clinical Outcome in Malignant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Viktoria Laszlo | Author(s): Thomas Klikovits, Anna Tisza, Maximilian Bonta, Mir Ali Reza Hoda, Walter Berger, Michael Grusch, Walter Klepetko, Balazs Hegedus, Andreas Limbeck, Balazs Dome
- Abstract
Loading... -
+
P2.06-22 - Proposal of a New Local Recurrence Score for Patients with Malignant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Walter Weder | Author(s): Olivia Lauk, Masaki Hashimoto, Martina Friess, Isabelle Opitz
- Abstract
Loading... -
+
P2.06-23 - Association of Two BRM Promoter Polymorphisms and Tobacco Exposure with Malignant Pleural Mesothelioma (MPM) Risk and Survival
16:45 - 18:00 | Presenter: Min Joon Lee | Author(s): Nathan Kuehne, Katrina Hueniken, Hadas Sorotsky, Mindy Liang, Devalben Patel, Dangxiao Cheng, Zhuo Chen, Lawson Eng, M Catherine Brown, John Cho, Natasha B Leighl, Marc De Perrot, David Reisman, Wei Xu, Penelope Bradbury, Geoffrey Liu
- Abstract
Loading... -
+
P2.06-24 - The Impact of Demographic and Socioeconomic Factors on Survival of Patients with Mesothelioma in the USA
16:45 - 18:00 | Presenter: Rami Manochakian | Author(s): Sikander Ailawadhi, Jordan Cochuyt, David Hodge, Yanyan Lou
- Abstract
Loading... -
+
P2.06-25 - Combined Immune Checkpoint Blockade in Malignant Pleural Mesothelioma: In Vivo Validation of in Vitro Results
16:45 - 18:00 | Presenter: Jan P Van Meerbeeck | Author(s): Elly Marcq, Jorrit De Waele, Jonas Van Audenaerde, Julie Jacobs, Jinthe Van Loenhout, Patrick Pauwels, Evelien Smits
- Abstract
Loading... -
+
P2.06-26 - Ribonucleotide Reductase Subunit M1 but not M2 is Associated to Better PFS in Patients with Advanced Stage Mesothelioma
16:45 - 18:00 | Presenter: Saé Muñiz-Hernández | Author(s): Laura-Alejandra RamÍrez-Tirado, Altagracia Maldonado, Daniel Hernandez-Cueto, Guillermina Baay-Guzman, Sara Huerta-Yepez, Oscar Arrieta
- Abstract
Loading... -
+
P2.06-27 - Extrapleural Pneumonectomy, Radiation Therapy, and Chemotherapy for Epithelioid Malignant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Kazunori Okabe | Author(s): Hidetoshi Inokawa, Masatarou Hayashi, Riki Okita, Masashi Furukawa, Marino Yamamoto
- Abstract
Loading... -
+
P2.06-28 - Assessment of Chest Wall Motion Using Structured Light Plethysmography (SLP) in Mesothelioma and Benign Pleural Disease
16:45 - 18:00 | Presenter: Nicola Oswald | Author(s): Amy Kerr, Rana Mehdi, Alice Turner, Babu Naidu
- Abstract
Loading... -
+
P2.06-29 - Expression of Estrogen Receptor Beta (ERb) and its Prognostic Value in the Pleural Mesothelioma.
16:45 - 18:00 | Presenter: Jeronimo Rafael Rodriguez-Cid | Author(s): Orlando García Acevedo, Diana Bonilla-Molina, Jorge Arturo Alatorre Alexander, Luis Martínez Barrera, Javier Benjamín Contreras, Erika Sagrario Peña Mirabal
- Abstract
Loading... -
+
P2.06-30 - Association of Histopathological Patterns of Mesothelioma and Response to Treatment with Chemotherapy
16:45 - 18:00 | Presenter: Jeronimo Rafael Rodriguez-Cid | Author(s): Diana Bonilla-Molina, Erika Sagrario Peña Mirabal, Jorge Arturo Alatorre Alexander, Luis Martínez Barrera, Julian Patricio Díaz Rico, Patricio Santillan Doherty
- Abstract
Loading... -
+
P2.06-31 - Inhibition of Heat Shock Protein 70 Function Suppresses Proliferation in Mesothelioma Cells
16:45 - 18:00 | Presenter: Kosuke Sakai | Author(s): Maya Inoue, Hiroaki Nishimura, Shintaro Mikami, Yoshiki Kuwabara, Akitoshi Kojima, Maiko Toda, Yumiko Kobayashi, Satoshi Kikuchi, Yusuke Hirata, Hiroyuki Kyoyama, Gaku Moriyama, Akihiko Gemma, Kazutsugu Uematsu
- Abstract
Loading... -
+
P2.06-32 - YB-1 - A Key Factor in Mesothelioma Aggressive Growth and Behaviour
16:45 - 18:00 | Presenter: Karin Schelch | Author(s): Thomas George Johnson, Kadir Harun Sarun, Andrew Burgess, Annette Lasham, Glen Reid
- Abstract
Loading... -
+
P2.06-33 - Heterogeneity in Care Pathways for Patients with Malignant Pleural Mesothelioma Presenting at a Quaternary Thoracic Oncology Center in Quebec
16:45 - 18:00 | Presenter: Aya Siblini | Author(s): Rola Hamed, Doneal Thomas, Julie Breau, Emma Lee, Sophie Camilleri-Broët, Pierre Olivier Fiset, Linda Ofiara, Stephane Beaudoin, Carmela Pepe, Bassam Abdulkarim, Neil Kopek, Hitesh Bhanabhai, Christian Sirois, Lorenzo Ferri, David Mulder, Jonathan David Spicer
- Abstract
Loading... -
+
P2.06-34 - Inhibition of the HGF/c-Met Pathway for Malignant Mesothelioma with an Intra-Thoracic Injection of the NK4 Expressing Adenoviral Vectors
16:45 - 18:00 | Presenter: Yuji Tada | Author(s): Takao Morinaga, Ikuo Sekine, Toshio Suzuki, Iwao Shimomura, Koichiro Tatsumi, Yuichi Takiguchi, Hideaki Shimada, Kenzo Hiroshima, Masatoshi Tagawa
- Abstract
Loading... -
+
P2.06-35 - Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma: SPARCS Data
16:45 - 18:00 | Presenter: Maaike Van Gerwen | Author(s): Raja Flores, Bian Liu, Andrea Wolf, Jorge Gomez, Emanuela Taioli
- Abstract
Loading... -
+
P2.06-36 - EORTC 1205: Randomized Phase II Study of Pleurectomy/Decortication Preceded or Followed by Chemotherapy in Early Stage MPM
16:45 - 18:00 | Presenter: Jan P Van Meerbeeck | Author(s): Jo Raskin, Veerle Surmont, Baktiar Hasan, Eleonora De Maio, Paul Emile Van Schil
- Abstract
Loading... -
+
P2.06-37 - Four Immunohistochemical Assays to Measure the PD-L1 Expression in Malignant Pleural Mesothelioma
16:45 - 18:00 | Presenter: Takuya Watanabe | Author(s): Katsuhiro Okuda, Satoru Moriyama, Hiroshi Haneda, Keisuke Yokota, Tsutomu Tatematsu, Tadashi Sakane, Risa Oda, Ryoichi Nakanishi
- Abstract
Loading... -
+
P2.06-38 - Mesothelioma Stem Cells May Be the Critical Factor of Treatment Failure
16:45 - 18:00 | Presenter: Licun Wu | Author(s): Mei-Lin Chan, Trevor McKee, Sehrish Butt, Michael Cabanero, Brenda J. Green, Bill T. V. Duong, Zhihong Yun, Mikihiro Kohno, Junichi Murakami, Yidan Zhao, Shana O. Kelley, Marc De Perrot
- Abstract
Loading... -
+
P2.06-39 - Next Generation Sequencing Reveals Genetic Landscape of Malignant Mesothelioma
16:45 - 18:00 | Presenter: Xuefeng Xia | Author(s): Jun Ren, Mingming Yuan, Yuguang Song, Lei Zhou, Jun Zhao, Yu Chen, Likun Chen, Wenxian Wang, Chunwei Xu, Rongrong Chen
- Abstract
Loading... -
+
P2.06-40 - VISTA is Highly Expressed in Malignant Pleural Mesothelioma (MPM) and Independent of PD-L1 Expression
16:45 - 18:00 | Presenter: Marjorie G. Zauderer | Author(s): Stephanie Muller, Wei-Chu Victoria Lai, Ai Ni, Achim Jungbluth, Michelle Ginsberg, Robert Daly, Matthew D. Hellmann, Marc Ladanyi, Jennifer Sauter
- Abstract
Loading... -
+
P2.06-41 - Differentiating Sarcomatoid Mesothelioma from Pleomorphic Carcinoma and Chest Wall Sarcoma Using GATA-3/MUC4/BAP1 IHC
16:45 - 18:00 | Presenter: Yu Zhi Zhang | Author(s): Toyin Adefila-Ideozu, Alex Bowman, Adam Januszewski, Sanjay Popat, Simon Jordan, Jan Lukas Robertus, Alexandra Rice, Miriam F Moffatt, William OC Cookson, Andrew G Nicholson
- Abstract
Loading... -
+
P2.06-42 - AXL, c-MET and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma.
16:45 - 18:00 | Presenter: Federica Zito Marino � | Author(s): Marina Accardo, Giuseppina Poziello, Andrea Ronchi, Vincenza Ciaramella, Gianmaria Vicidomini, Mario Santini, Floriana Morgillo, Renato Franco
- Abstract
Loading...
-
+
P2.09 - Pathology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.09-01 - Tumor-Associated Immune Cell Infiltration Patterns in Early Stage Squamous Lung Carcinoma
16:45 - 18:00 | Presenter: Hui Yu | Author(s): Daniel T Merrick, Ming Sound Tsao, William G Richards, Lucian R Chirieac, Mark Watson, Christopher J. Rivard, David Harpole, Raphael Bueno, Adrian van Bokhoven, Fred R. Hirsch, Wilbur A. Franklin
- Abstract
Loading... -
+
P2.09-02 - Comprehensive Assessment of PD-L1 Immunohistochemistry on Paired Tissue and Cytology Specimens in Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Andréanne Gagné | Author(s): Michèle Orain, Diana N. Ionescu, Ming Sound Tsao, David Joubert, Philippe Joubert
- Abstract
Loading... -
+
P2.09-03 - Rapid-Immunocytochemistry for Evaluation of Surgical Margin in Sublobar Pulmonary Resection
16:45 - 18:00 | Presenter: Nobuyasu Kurihara | Author(s): Hajime Saito, Hiroshi Nanjo, Yuko Hiroshima, Kazuhiro Imai, Hayato Konno, Maiko Atari, Tsubasa Matsuo, Shinnosuke Watanabe, Hidenobu Iwai, Haruka Suzuki, Yoshihiro Minamiya
- Abstract
Loading... -
+
P2.09-04 - PD-L1 Expression in Primary Lung Adenocarcinoma and its Relation with EGFR / KRAS Mutation and Clinicopathological Features
16:45 - 18:00 | Presenter: Lin Li | Author(s): Changyuan Guo, Lei Guo, Hongshuang Dai, Jianming Ying, Yanning Gao
- Abstract
Loading... -
+
P2.09-05 - Evaluation of PD-L1-Stained Tumor Cells via the 22C3 and SP-142 Antibodies in Cohort of Patients Treated on KEYNOTE-001
16:45 - 18:00 | Presenter: Aaron Lisberg | Author(s): Siwen Hu-Lieskovan, Tristan Grogan, James Carroll, Peter Shintaku, Mary Han, Dennis Slamon, Steven M Dubinett, Jonathan W. Goldman, David Elashoff, Matthew D. Hellmann, Antoni Ribas, Edward B Garon
- Abstract
Loading... -
+
P2.09-06 - Expression of PD-L1 on Routine Non-Small Cell Lung Carcinoma Sections: Comparative Assessment of SP263 (Ventana) and 22C3 (DAKO pharmDx)
16:45 - 18:00 | Presenter: Anne Marie Quinn | Author(s): John Roy Gosney, Paul Bishop, Rebecca Bloor, Christopher Harreld, Catherine McNulty, Rachel Bowden, Anna Moss, Steven Forrest, Angeles Montero, Anshuman Chaturvedi, Leena Joseph, Antonio Paiva-Correia, Helen Doran, Philippe Taniere, Phillip Crosbie, Fiona Blackhall, Yvonne Summers
- Abstract
Loading... -
+
P2.09-07 - Does Metastatic Site Matter for PD-L1 Testing in Stage IV NSCLC?
16:45 - 18:00 | Presenter: Hangjun Wang | Author(s): Jason S Agulnik, Goulnar Kasymjanova, Pierre Olivier Fiset, Sophie Camilleri-Broët, Margaret Redpath, David Small, Victor Cohen, Alan Spatz
- Abstract
Loading... -
+
P2.09-08 - Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Ying Wang | Author(s): Martin Butcher, Asghar Naqvi, Jean-Claude Cutz, Rosalyn Juergens
- Abstract
Loading... -
+
P2.09-09 - Precision and Repeatability of VENTANA DLL3 (SP347) Assay Immunohistochemistry Assay in Fine Needle Aspirations of Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Brittany Admire | Author(s): Burton Holmes, Ehab Elgabry, Courtney Powell, Dusty Tyree, Raji Marati, Amy Elizabeth Hanlon Newell, Bita Damadzadeh, Deepa Dalvi, Richard S.P. Huang
- Abstract
Loading... -
+
P2.09-10 - qRT-PCR as an Efficient and Reliable Diagnostic Screening Approach for the Detection of EML4-ALK Fusion Gene in NSCLC Samples: A Pilot Study
16:45 - 18:00 | Presenter: Anuradha Choughule | Author(s): Vanita Noronha, Shripad Banavali, Priyanka Bagayatkar, kumar Prabhash
- Abstract
Loading... -
+
P2.09-11 - TMB Estimated with Targeted NGS in Early Stage Squamous Cell Carcinoma: Correlation with PD-L1 Expression and Lymphocyte Density
16:45 - 18:00 | Presenter: Susana Hernandez | Author(s): Barbara Angulo, Carolina Dominguez, Alejandra Caminoa, Alfonso Muriel, Marta Alonso, Luis Jimenez, Rafael Peñalver, Ana Collazo-Lorduy, Beatriz Jimenez, Pilar Garrido, Luis Paz-Ares, Javier De Castro, Esther Conde, Fernando Lopez-Rios
- Abstract
Loading... -
+
P2.09-12 - EGFR Mutation Status in Squamous Cell Carcinoma or Non-Small Cell Carcinoma Favor Squamous Cell Carcinoma Diagnosed from Small Lung Biopsies
16:45 - 18:00 | Presenter: Hsiang-Ling Ho | Author(s): Hua-Lin Kao, Teh-Ying Chou
- Abstract
Loading... -
+
P2.09-13 - Correlation of ROS1 (SP384) Immunohistochemistry with ROS1 Rearrangement Determined by Fluorescence in Situ Hybridization
16:45 - 18:00 | Presenter: Catherine H Le | Author(s): Richard S.P. Huang, Derek Smith, Bill Richardson, Wen-Wei Liu, Amy Elizabeth Hanlon Newell, Greg Pate, Ina Menzl
- Abstract
Loading... -
+
P2.09-14 - The Detection of EGFR Gene Mutation from Washing Solution of Devices used for the Bronchoscopic Examination
16:45 - 18:00 | Presenter: Rie Nakahara | Author(s): Takashi Kasai, Yukari Kamiyama, Youichi Nakamura, Tomohide Sugiyama, Ikuma Wakamatsu, Nobuo Hoshi, Kimiko Nakano, Haruhisa Matsuguma
- Abstract
Loading... -
+
P2.09-15 - A Next Generation Sequencing (NGS) RNA-Scan Multiplex Panel (QIAseq) to Identify Gene-Rearranged Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Rebecca Y Tay | Author(s): Shuwen Huang, Mathew Carter, Andrew Wallace, Fiona Blackhall
- Abstract
Loading... -
+
P2.09-16 - Heterogeneity Analyses of MSLCs——Especially in the EGFR Mutation-Positive Ones
16:45 - 18:00 | Presenter: Yinghui Xu | Author(s): Xu Wang, Yangyang Cai, Ye Guo, Chao Sun, Kewei Ma
- Abstract
Loading... -
+
P2.09-17 - A Call to Action: Rapid Collection of Post-Mortem Lung Cancer Tissue in the Community to Enable Lung Cancer Research
16:45 - 18:00 | Presenter: Theresa A Boyle | Author(s): Gwendolyn P. Quinn, Mathew B. Schabath, Teresita Munoz-Antonia, Luisa F. Duarte, Christie L. Pratt, Dung Tsa Chen, Laura S. Hair, Scott J Antonia, Alberto A. Chiappori, Ben C. Creelan, Jhanelle Elaine Gray, Charles C. Williams, Eric B. Haura
- Abstract
Loading... -
+
P2.09-18 - A Clinicopathologic Analysis of Pulmonary Sclerosing Pneumocytoma in Korea : A Muticenter Study
16:45 - 18:00 | Presenter: Han Kyeom Kim | Author(s): Seung Yeon Ha, Myung Hee Kang, Mee Sook Roh, Korean Society of Pathologists The Cardiopulmonary Pathology Study Group
- Abstract
Loading... -
+
P2.09-19 - Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment
16:45 - 18:00 | Presenter: Alexander Haragan | Author(s): John Kirkpatrick Field, Michael P A Davies, Carles Escriu, Aaron Gruver, John Roy Gosney
- Abstract
Loading... -
+
P2.09-20 - Minor Components of Solid Pattern is a Significant Poor Prognostic Factor in Pathological Stage I Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Miao Huang | Author(s): Shaolei Li, Yue Yang
- Abstract
Loading... -
+
P2.09-21 - Women with Synchronous or Metachronous Lung and Ovarian Cancers: A Multi-Institutional Report
16:45 - 18:00 | Presenter: Silvia Novello | Author(s): Annapaola Mariniello, Eleonora Ghisoni, Luisella Righi, Annamaria Catino, Rita Chiari, Alessandro Del Conte, Fausto Barbieri, Fabiana Letizia Cecere, Alain Gelibter, Matteo Giaj Levra, Hector Josè Soto Parra, Clizia Zichi, Giorgio Valabrega
- Abstract
Loading... -
+
P2.09-22 - Relevance of Results of Intraoperative Pleural Lavage Cytology and Histological Subtype in Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Masashi Mikubo | Author(s): Raito Maruyama, Keigo Matsushima, Shoko Hayashi, Masahito Naito, Yoshio Matsui, Kazu Shiomi, Masaaki Ichinoe, Tsutomu Yoshida, Kennichi Satoh
- Abstract
Loading... -
+
P2.09-23 - A Combination of Podoplanin and E-Cadherin Expression in Lung SqCC may be a Poor Prognostic Indicator: A Propensity Score-Matched Analysis.
16:45 - 18:00 | Presenter: Ryo Miyata | Author(s): Toshi Menju, Misa Noguchi, Hiroyuki Ishikawa, Shigeto Nishikawa, Koji Takahashi, Masatsugu Hamaji, Daisuke Nakajima, Akihiro Ohsumi, Toyofumi Fengshi Chen-Yoshikawa, Toshihiko Sato, Makoto Sonobe, Hiroshi Date
- Abstract
Loading... -
+
P2.09-24 - MERS67 is a Novel anti-NaPi2b Antibody and Demonstrates Differential Expression Patterns in Lung Cancer Histologic Subtypes
16:45 - 18:00 | Presenter: Rebecca Mosher | Author(s): Hui Yu, Kim Ellison, Pamela Shaw, Rafal Dziadziuszko, Eric Hailman, Christopher J. Rivard, Fred R. Hirsch
- Abstract
Loading... -
+
P2.09-25 - Abundant Tumor Promoting Stromal Cells in Lung Adenocarcinoma with Hypoxic Regions
16:45 - 18:00 | Presenter: Hiroshi Nakamura | Author(s): Tomohiro Ichikawa, Shoko Nakasone, Keiju Aokage, Masahiro Tsuboi, Kenji Suzuki, Genichirou Ishii
- Abstract
Loading... -
+
P2.09-26 - Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Takashi Ohno | Author(s): Yuji Nosaka, Wakako Fujiwara, Tatsuya Miyamoto, Taichi Kadonaga, Yoshiteru Kidokoro, Makoto Wakahara, Yuzo Takagi, Yuko Tanaka, Tomohiro Haruki, Ken Miwa, Yoshimasa Suzuki, Yuji Taniguchi, Hiroshige Nakamura, Yoshihisa Umekita
- Abstract
Loading... -
+
P2.09-27 - Prognostic Significance of Vascular Invasion in Pathological Stage IA Lung Adenocarcinoma According to the 8th Edition of the TNM Classification
16:45 - 18:00 | Presenter: Joji Samejima | Author(s): Tomoyuki Yokose, Hiroyuki Ito, Haruhiko Nakayama, Takuya Nagashima, Junichiro Osawa, Kenji Inafuku, Hidehiko Yagasaki, Masaki Suzuki, Kouzo Yamada, Munetaka Masuda
- Abstract
Loading... -
+
P2.09-28 - Detection of Isolated Tumor Cells in Regional Lymph Nodes from pN0 Lung Cancer by Negative Selection Using Immunomagnetic Beads
16:45 - 18:00 | Presenter: Xizhao Sui | Author(s): Ganwei Liu, Jun Wang
- Abstract
Loading... -
+
P2.09-29 - Automatic Lung Cancer Staging from Medical Reports Using Natural Language Processing
16:45 - 18:00 | Presenter: Xizhao Sui | Author(s): Taorui Liu, Qi Huang, Yanyan Hou, Yun Wang, Guannan Kang, Haifa Guo, Ning Li, Yanan Li, Zhicong Wang, Jun Wang
- Abstract
Loading... -
+
P2.09-30 - Clinicopathological Investigation of Four Resected Cases for Pleomorphic Carcinoma of the Lung
16:45 - 18:00 | Presenter: Kenichi Taguchi | Author(s): Hiroaki Inoue, Osamu Kawamata
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.09-32 - Detached Epithelial Cell Cluster Size in Lung Adenocarcinoma is a Marker of Poor Prognosis
16:45 - 18:00 | Presenter: Akihiko Yoshizawa | Author(s): Kyoko Kondo, Naoki Nakajima, Yuki Teramoto, Mariyo Rokutan-Kurata, Shinji Sumiyoshi
- Abstract
Loading...
-
+
P2.10 - Prevention and Tobacco Control (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.10-01 - Success of a Pharmacy-Driven Smoking Cessation Program
16:45 - 18:00 | Presenter: Catherine E Burdalski | Author(s): Stacy Dalpoas, Josephine Feliciano, Margaret Lang, Bryna Ewachiw
- Abstract
Loading... -
+
P2.10-02 - Variations in Smoking Cessation Activities at Ontario’s Regional Cancer Centres
16:45 - 18:00 | Presenter: William Kenneth Evans | Author(s): Naomi Schwartz, Mohammad Haque, Erin Cameron, Sahara Khan, Rebecca Truscott, Alice Peter
- Abstract
Loading... -
+
P2.10-03 - Feasibility and Acceptability of E-Cigarettes as an Aid to Quitting Smoking in Lung Cancer Patients: A Pilot Study
16:45 - 18:00 | Presenter: Stephen James Harrow | Author(s): Linda Bauld, Jennifer Macphee, Allison Ford, Lesley Sinclair, Jennifer McKell, Andy Morrison
- Abstract
Loading... -
+
P2.10-04 - Pattern and Factors Associated with Intention to Quit Tobacco Use in a Rural Community of Anambra State of Nigeria
16:45 - 18:00 | Presenter: Uzochukwu Ofonakara | Author(s): Marycynthia Ndidiamaka Ilo, Angela Okocha Ejeko, Chiamaka Queen Ikpe
- Abstract
Loading... -
+
P2.10-05 - Provider Medical Specialty Influences Smoking Cessation Counseling at an Academic Medical Center and Veterans Affairs in U.S. Mid-South
16:45 - 18:00 | Presenter: Jennifer A. Lewis | Author(s): Heidi Chen, Kathryn E Weaver, Lucy B Spalluto, Kim L. Sandler, Leora Horn, Robert S. Dittus, Pierre P Massion, Christianne L. Roumie, Hilary A Tindle
- Abstract
Loading... -
+
P2.10-06 - The Risk of Lung Cancer Among Women Who Start Smoking As Teenagers
16:45 - 18:00 | Presenter: Malcolm Tagbarha
- Abstract
Loading... -
+
P2.10-07 - Health Professional’s Perception Towards Smoking: A Cross-Sectional Study from Bangalore, India.
16:45 - 18:00 | Presenter: Satheesh Chiradoni Thungappa | Author(s): Rashmi Nulenur Rajappa, Raghavendra Rao, Mohamed Saleel
- Abstract
Loading... -
+
P2.10-08 - Smoking Prevention Project in School Population: My Health Is in My Own Hands
16:45 - 18:00 | Presenter: Tomi Kovacevic | Author(s): Darijo Bokan, Bojan Zaric, Vladimir Stojsic, Tatjana Boskovic, Petar Simurdic, Aleksandra Andjelkovic, Ivan Ergelasev, Jelena Stanic
- Abstract
Loading... -
+
P2.10-09 - The Beliefs, Orientation, Knowledge, Understanding, Attitudes And Treatment Access To Lung Cancer Amongst Rural Men In Nigeria
16:45 - 18:00 | Presenter: Malcolm Tagbarha
- Abstract
Loading... -
+
P2.10-10 - Lung Cancer Survival in Younger Patients (<40 Years): Analysis of Surveillance, Epidemiology and End Results Program Data
16:45 - 18:00 | Presenter: Marisa Bittoni | Author(s): James Fisher
- Abstract
Loading... -
+
P2.10-11 - Impact of Smoking on Multiple Primary Cancers Survival – A Retrospective Analysis
16:45 - 18:00 | Presenter: Anna Doboszyńska | Author(s): Anna Maria Romaszko-Wojtowicz, Adam Buciński
- Abstract
Loading... -
+
P2.10-12 - Prevalence, Pattern and Factors Associated with Dual Tobacco Use in a Rural Community in South Eastern Nigeria
16:45 - 18:00 | Presenter: Uzochukwu Ofonakara | Author(s): Marycynthia Ndidiamaka Ilo, Oluwakemi Odukoya, Chiamaka Queen Ikpe
- Abstract
Loading... -
+
P2.10-13 - When Lung Cancer Was Rare: An Historical Study of
Prevalence from 176016:45 - 18:00 | Presenter: Luc Ollivier | Author(s): Philippe Saliou, Ollivier Pradier, Ulrike Schick, Christophe Roge
- Abstract
Loading... -
+
P2.10-14 - The Evalution of Relationship Between Radon Gas and Lung Cancers in Trabzon
16:45 - 18:00 | Presenter: Fazıl Aydın | Author(s): Esra Asık, Elanur Karaman, Feyyaz Ozdemir, Celal Alandag
- Abstract
Loading... -
+
P2.10-15 - RADON: #1 Cause of Lung Cancer in Non-Smokers
16:45 - 18:00 | Presenter: Kelley Bush
- Abstract
Loading... -
+
P2.10-16 - Finding the Relations Between Lung Cancer and Associated Risk Factors in Pakistani Population
16:45 - 18:00 | Presenter: Arooj Fatima | Author(s): Syed Sammar Abbas Zaidi
- Abstract
Loading... -
+
P2.10-17 - Environmental Tobacco Smoke Exposure and EGFR Mutations in Non-Smokers with Lung Cancer: A Dose-Response Analysis of Published Data
16:45 - 18:00 | Presenter: Wenhua Liang | Author(s): Hengrui Liang, Zhichao Liu, Guanping Qiu, Yaokai Wen, Jianxing He
- Abstract
Loading...
-
+
P2.11 - Screening and Early Detection (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.11-01 - Blood Transcriptomics Enables Detection of Pre-Invasive & Minimally-Invasive Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Fangfei Qian, Wenjia Yang, Xiang Zuo, Jie Qian, Bo Zhang, Shuyuan Wang, Lele Zhang
- Abstract
Loading... -
+
P2.11-02 - Direct Comparison of New Solid Nodules Detected in Women and Men During Incidence Screening Rounds of the NELSON Trial
16:45 - 18:00 | Presenter: Joan E Walter | Author(s): Marjolein A Heuvelmans, Rozemarijn Vliegenthart, Peter Van Ooijen, Harry J De Koning, Matthijs Oudkerk
- Abstract
Loading... -
+
P2.11-03 - Cardiovascular Risk Prediction in a Community-Based Lung Cancer Screening Programme
16:45 - 18:00 | Presenter: Haval Balata | Author(s): Matthew Evison, Richard Booton, Phillip Crosbie
- Abstract
Loading... -
+
P2.11-04 - Treatment Capacity Required for Implementing Lung Cancer Screening in the United States
16:45 - 18:00 | Presenter: Erik Ferdinand Blom | Author(s): Kevin ten Haaf, Douglas Arenberg, Harry J De Koning
- Abstract
Loading... -
+
P2.11-06 - A New Histoplasmosis Antibody Enzyme Immunoassay for the Diagnosis of Lung Benign Nodules
16:45 - 18:00 | Presenter: Stephen Deppen | Author(s): Eric Grogan, Pierre P Massion
- Abstract
Loading... -
+
P2.11-07 - Lung Cancer in a Tertiary Care Setting: So Near, Yet So Far
16:45 - 18:00 | Presenter: Kranti Garg | Author(s): Sanjeev Kumar Binji, Varinder Saini, Shivani Jaswal, Uma Handa, Jasbinder Kaur
- Abstract
Loading... -
+
P2.11-08 - Tumor Autoantibody Panel Can Improve the Accuracy of Early Diagnosis in Lung Cancer Presenting with GGNs /Solid Nodules
16:45 - 18:00 | Presenter: Yayi He | Author(s): Caicun Zhou, Fred R. Hirsch
- Abstract
Loading... -
+
P2.11-09 - Uncommon EGFR Mutation Analysis from Urine of Lung Cancer Patients
16:45 - 18:00 | Presenter: Prista Kusumaningtyas Hikmawati | Author(s): Farizul Fadiyah, Fadillah Putri Patria, Asep Muhamad Ridwanuloh, Achmad Hudoyo, Jamal Zaini, Sita Andarini, Ahmad Rusdan Utomo
- Abstract
Loading... -
+
P2.11-10 - Potential Utility of a Positive EarlyCDT®-Lung Blood Biomarker Test in Indeterminate Pulmonary Nodules
16:45 - 18:00 | Presenter: James Jett | Author(s): Graham F Healey, Andrea Murray, Geoffrey Hamilton-Fairley, Stuart Fraser, Laura J Peek, Peter Mazzone, Pierre P Massion
- Abstract
Loading... -
+
P2.11-11 - Identification of the Genetic Determinants of Susceptibility to Lung Cancer in a Moroccan Cohort
16:45 - 18:00 | Presenter: Houda Kaanane | Author(s): Hind Berradi, Nadia Benchakroun, Abdellatif Benider, Nezha Senhaji, Sellama Nadifi
- Abstract
Loading... -
+
P2.11-12 - Metabolomic Analysis in Lung Cancer for Screening and Early Detection
16:45 - 18:00 | Presenter: Naohiro Kajiwara | Author(s): Sachio Maehara, Hisayoshi Shimada, Junichi Maeda, Masaru Hagiwara, Tetsuya Okano, Masatoshi Kakihana, Tatsuo Ohira, Masahiro Sugimoto, Norihiko Ikeda
- Abstract
Loading... -
+
P2.11-13 - Precise Early Detection of Lung Cancer and Blood Cell Circuit
16:45 - 18:00 | Presenter: Oleg Kshivets
- Abstract
Loading... -
+
P2.11-14 - Malignancy Associated Change and The LuCED® Test for Detection of Early Stage Lung Cancer
16:45 - 18:00 | Presenter: Michael Meyer | Author(s): Laimonas Kelbauskas, Rahul Katdare, Chris Presley, Celeste Hamilton, Daniel J Sussman, Tim Bell, Alan Nelson
- Abstract
Loading... -
+
P2.11-15 - Identifying Patients for Whom Lung Cancer Screening is Preference-Sensitive: A Microsimulation Study
16:45 - 18:00 | Presenter: Rafael Meza | Author(s): Tanner J Caverly, Pianpian Cao, Rodney A Hayward
- Abstract
Loading... -
+
P2.11-16 - Comparison of Two Lung Cancer Screening Programs in One Medical Center - Does Experience of the Screening Team and Indications Affect the Results?
16:45 - 18:00 | Presenter: Marcin Ostrowski | Author(s): Tomasz Marjanski, Robert Dziedzic, Malgorzata Jelitto-Gorska, Katarzyna Dziadziuszko, Witold Rzyman
- Abstract
Loading... -
+
P2.11-17 - MicroRNAs in Exhaled Breath Condensate and Bronchial Brushings as Biomarkers for Early Diagnosis of Lung Cancer
16:45 - 18:00 | Presenter: Bijay Pattnaik | Author(s): Samarpana Chakraborty, Prashant Bajpai, Anurag Agrawal, Randeep Guleria, Anant Mohan
- Abstract
Loading... -
+
P2.11-18 - A Comprehensive Lung Cancer Screening Program: 5 Years in Review
16:45 - 18:00 | Presenter: April Plank | Author(s): Michael Reiter, Lisa Reagan, Barbara Nemesure
- Abstract
Loading... -
+
P2.11-19 - MicroRNAs as Liquid Biopsy Biomarkers for Early Detection in Lung Cancer.
16:45 - 18:00 | Presenter: Patricia Reis | Author(s): Melania Pintilie, Igor Jurisica, Geoffrey Liu, Ming Sound Tsao
- Abstract
Loading... -
+
P2.11-20 - Lung EpiCheck TM - Results of the Training and Test Sets of a Methylation-Based Blood Test for Early Detection of Lung Cancer
16:45 - 18:00 | Presenter: Joanna Chorostowska-Wynimko | Author(s): I Horváth, D Shitrit, VH Eisenberg, D Stav, D Levy Faber, Piotr Rudzinski, MAM Jansen, Y Raviv, V Panagoulias, G Izbicki, O Ronen, A Goldhaber, R Moalem, N Arber, R Shahien, I Haas, Mina Gaga
- Abstract
Loading... -
+
P2.11-21 - Factors Predicting Attrition in Community-Based Healthcare Network Lung Cancer Screening Programs
16:45 - 18:00 | Presenter: Candice Leigh Wilshire | Author(s): Kristin Mary Spiegel, Joshua Robert Rayburn, Erika H Rauch, John R Handy, Christopher R Gilbert, Roshanthi K Weerasinghe, Gary L Grunkemeier, Shu-Ching Chang, Jed A Gorden
- Abstract
Loading... -
+
P2.11-22 - Use of Electronic Medical Records for Tobacco Use and Lung Cancer Screening Documentation in a Large Urban Academic Medicine Practice
16:45 - 18:00 | Presenter: Giselle Alexandra Suero-Abreu | Author(s): Keishondra Sampson, JunChih Wang, Analise Y Douglas, Aris Karatasakis, Arturo Perez, Narjust Duma, Miguel Gonzalez Velez, Mirela Feurdean, Tracy Proverbs-Singh, Martin Gutierrez
- Abstract
Loading... -
+
P2.11-23 - Risk Perception Among a Lung Cancer Screening Population
16:45 - 18:00 | Presenter: John R Goffin | Author(s): Jane Turner, Greg R Pond, Alain Tremblay, Michael Johnston, Glenwood Goss, Garth Nicholas, Simon Martel, Rick Bhatia, Geoffrey Liu, Heidi Schmidt, Martin Tammemägi, Serge Puksa, Sukhinder Atkar-Khattra, Ming Sound Tsao, Stephen Lam
- Abstract
Loading... -
+
P2.11-24 - Impact of Screening Interval Length on New Nodules Detected in Incidence Rounds of CT Lung Cancer Screening: the NELSON Trial
16:45 - 18:00 | Presenter: Joan E Walter | Author(s): Marjolein A Heuvelmans, Rozemarijn Vliegenthart, Peter Van Ooijen, Harry J De Koning, Matthijs Oudkerk
- Abstract
Loading... -
+
P2.11-25 - Lung Cancer Screening Implementation in Community Practice: Kaiser Permanente Washington Experience 2015-2018
16:45 - 18:00 | Presenter: Karen Wernli | Author(s): Hongyuan Gao, Johanne Leblanc, Jennifer Nazarko, Diana SM Buist
- Abstract
Loading... -
+
P2.11-26 - First of its Kind Multi-Pronged Training for PCPs in an Epicenter of Lung Cancer – What Was Achieved in Two Years?
16:45 - 18:00 | Presenter: Celeste T. Worth | Author(s): Morel Jones, Ruth Mattingly, Connie Sorrell, Jamie L Studts
- Abstract
Loading... -
+
P2.11-27 - A Rapid Access Lung Cancer Clinic Reduces Variation in Lung Cancer Diagnostic and Treatment Services.
16:45 - 18:00 | Presenter: Robert Zielinski | Author(s): Thabisa Sibanda, Charles Prabhakar, Florian Honeyball, Kandeepan Thuraisingam, Kim Turley, Joel Begnell, Sugamya Mallwathantri
- Abstract
Loading... -
+
P2.11-28 - A Focus Group and Interview Study to Explore the Information-Needs of Lung Cancer Screening Participants
16:45 - 18:00 | Presenter: Mamta Ruparel | Author(s): Samantha Quaife, David Raymond Baldwin, Sam M Janes, Josephine Waller
- Abstract
Loading... -
+
P2.11-29 - Impact of an Information-Film to Promote Informed Decision-Making in Individuals Taking Part in a Lung Cancer Screening Demonstration Pilot
16:45 - 18:00 | Presenter: Mamta Ruparel | Author(s): Samantha Quaife, Bhagabhati Ghimire, Jennifer Dickson, Carolyn Horst, Sophie Tisi, Angshu Bhowmik, Neal Navani, David Raymond Baldwin, Stephen Duffy, Josephine Waller, Sam M Janes
- Abstract
Loading... -
+
P2.11-29a - Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non–Smoking-Related Lung Cancer
16:45 - 18:00 | Presenter: En-Kuei Tang | Author(s): FU ZONG Wu
- Abstract
Loading...
-
+
P2.12 - Small Cell Lung Cancer/NET (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.12-01 - Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study
16:45 - 18:00 | Presenter: Jin-Hyoung Kang | Author(s): Ki Hyeong Lee, Dong-Wan Kim, Sang-We Kim, Hye Ryun Kim, Joo-Hang Kim, Jin Hyuk Choi, Ho Jung An, Jin-Soo Kim, Joung Soon Jang, Bong-Seog Kim, Heung Tae Kim
- Abstract
Loading... -
+
P2.12-02 - Phase II Study of Combination of Nab-Paclitaxel and Gemcitabine for Relapsed Small Cell Lung Cancer (SCLC)
16:45 - 18:00 | Presenter: Muhammad Furqan | Author(s): Jun Zhang, Gerald Clamon, Tajer Abu-Hejleh
- Abstract
Loading... -
+
P2.12-03 - Phase I/II Trial Of 177Lu-DOTA0-Tyr3-Octreotate (Lutathera) And Nivolumab for Patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
16:45 - 18:00 | Presenter: Chul Kim | Author(s): Deepa S Subramaniam, Stephen V Liu, Giuseppe Giaccone
- Abstract
Loading... -
+
P2.12-04 - Liposomal Irinotecan vs Topotecan in Patients with Small Cell Lung Cancer Who Have Progressed On/After Platinum-Based Therapy
16:45 - 18:00 | Presenter: Natalya Nazarenko | Author(s): Luis Paz-Ares, James Chih-Hsin Yang, Christoph Zielinski, Silvia Novello, Gilberto Schwartsmann, David R. Spigel, Frank Griesinger, Afshin Dowlati, Tania Small, Floris A. De Jong, Bin Zhang, Paul A. Bunn, Jr.
- Abstract
Loading... -
+
P2.12-05 - SUKSES (Small Cell Lung Cancer Umbrella Korea Studies): A Phase II Biomarker-Driven Umbrella Study in Relapsed or Refractory SCLC
16:45 - 18:00 | Presenter: Keunchil Park | Author(s): Sehhoon Park, Joon Young Hur, Sang Eum Yoon, Kangkook Lee, Youjin Kim, Jang Ho Cho, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn
- Abstract
Loading... -
+
P2.12-06 - The Efficacy of Apatinib Plus Topotecan as Laterline Therapy for Advanced Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Haifeng Qin | Author(s): Hongjun Gao
- Abstract
Loading... -
+
P2.12-07 - Utility of Stereotactic Body Radiotherapy in Pulmonary Carcinoid Tumors
16:45 - 18:00 | Presenter: Robert A Ramirez | Author(s): Brianne A Voros, Paul N. Page, J. Philip Boudreaux, Ramcharan Thiagarajan, Eugene A. Woltering
- Abstract
Loading... -
+
P2.12-08 - Network Meta-Analysis of Angiogenesis Inhibitors on Survival of Patients with Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Xiaoshun Shi | Author(s): Xiguang Liu, Yuanyuan Wang, Di Lu, Xiaoying Dong, Siyang Feng, Kaican Cai
- Abstract
Loading... -
+
P2.12-09 - Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease with Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Ayumi Uchiyama | Author(s): Yoshiaki Nagai, Ayako Takigami, Masafumi Sata, Koichi Hagiwara
- Abstract
Loading... -
+
P2.12-10 - Novel Prognostic Model for Limited-Stage Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Hanbo Chen | Author(s): Andrew Warner, Emma Ali, George Rodrigues, Alexander Louie
- Abstract
Loading... -
+
P2.12-11 - A Prognostic Model Integrating Immunohistochemistry Markers for Extensive-Disease Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Rui Fu | Author(s): Chao Zhang, Jia-Tao Zhang, Jin -Ji Yang, Qing Zhou, Xue-Ning Yang, Yi-Long Wu, Wen-zhao Zhong, Jie Huang
- Abstract
Loading... -
+
P2.12-12 - Plasma Vitamin D Level is an Independent Prognosis Factor in SCLC Patients Treated with Platinum Plus Etoposide as First-Line Chemotherapy
16:45 - 18:00 | Presenter: Xu Wang | Author(s): Chang xiao Zhang, Kewei Ma, Wei Li
- Abstract
Loading... -
+
P2.12-13 - Effectiveness of Hypofractionated Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: A Propensity Score Analysis
16:45 - 18:00 | Presenter: Hanbo Chen | Author(s): Emma Ali, David Palma, George Rodrigues, Alexander Louie
- Abstract
Loading... -
+
P2.12-14 - Stereotactic Radiosurgery for Brain Metastases in Small Cell Lung Cancer.
16:45 - 18:00 | Presenter: Elizabeth Dudnik | Author(s): Shlomit Yust-Katz, Natalia Michaeli, Tzippy Shochat, Nir Peled, Alona Zer, Ofer Rotem, Aaron M. Allen
- Abstract
Loading... -
+
P2.12-15 - Prognostic and Predictive Covariates in Limited-Stage Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial
16:45 - 18:00 | Presenter: Corinne Faivre-Finn | Author(s): Ahmed Salem, Hitesh Mistry, Sally Falk
- Abstract
Loading... -
+
P2.12-16 - Significant Tumor Regression and Toxicity with Nivolumab Plus Ipilimumab in Small Cell Lung Cancer Patients Following Radiation
16:45 - 18:00 | Presenter: Brendan Gilmore | Author(s): Marta Batus, Mary Jo Fidler, Gaurav Marwaha, Philip Bonomi
- Abstract
Loading... -
+
P2.12-17 - Prophylactic Cranial Irradiation Can Not Provide Survival Benefits for Resected Small Cell Lung Cancer Without Lymph Node Involvement
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jianlin Xu, Rong Qiao, Jiajun Teng, Bo Zhang, Shuyuan Wang, Jie Qian, Yuqing Lou, Yanwei Zhang, Xueyan Zhang, Xiaolong Fu, Tianqing Chu, Hua Zhong
- Abstract
Loading... -
+
P2.12-18 - Interstitial Lung Abnormalities are a Risk Factor for Radiation Pneumonitis in Patients with Limited-Stage Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Fangjuan Li | Author(s): Shixiong Liang, Hongyu Wu, Yong Cai, Yaping Xu, Ming Chen
- Abstract
Loading...
-
+
P2.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.13-01 - Brigatinib Use in England – Where Next?
16:45 - 18:00 | Presenter: Fabio Gomes | Author(s): Kent Yip, Fiona Blackhall, Alastair Greystoke, Raffaele Califano, Sharmistha Ghosh, Thomas Newsom-Davis, Henrietta Mills, Samreen Ahmed, Amelie Harle, Yvonne Summers
- Abstract
Loading... -
+
P2.13-02 - ALK-Translocation and Brain Metastases: A Retrospective Study. Correlation Between Clinical Outcome, Disease Burden and Management.
16:45 - 18:00 | Presenter: Oscar Grundberg | Author(s): Signe Friesland, Samy Abdel-Halim, Sebastian Gagatek, Reza Karimi, Anna Öjdahl-Boden, Georgios Tsakonas, Maja Bradic-Lindh, Karl-Gustav Kölbeck, Gunnar Wagenius, Simon Ekman, Karin Lindberg, Luigi De Petris
- Abstract
Loading... -
+
P2.13-03 - Real-Life Experience with Brigatinib in Pretreated EML4-ALK Translocated NSCLC Patients
16:45 - 18:00 | Presenter: Maximilian Johannes Hochmair | Author(s): Jakob Naber, Sophia Schwab, Ulrike Setinek, Dagmar Krenbek, Marcel Holzer, Hannah Fabikan, Stefan Watzka, Renate Koger, Andreas Fazekas, Erwin Bitterlich, Arschang Valipour, Otto Chris Burghuber
- Abstract
Loading... -
+
P2.13-04 - Outcomes of ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib: A Multicenter Cohort Retrospective Study.
16:45 - 18:00 | Presenter: Di Ma | Author(s): Puyuan Xing, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P2.13-05 - Real-World Clinical Benefit of Continuing Crizotinib Beyond Progression Disease (CBPD) in Patients with Advanced ALK-Positive NSCLC.
16:45 - 18:00 | Presenter: Di Ma | Author(s): Puyuan Xing, Qiang Wang, Xuezhi Hao, Mengzhao Wang, Yan Wang, Li Shan, Tao Xin, Li Liang, Hongge Liang, Yang Du, Zhaohui Zhang, Junling Li
- Abstract
Loading... -
+
P2.13-06 - TP53 Status in Relation to Response to Anti-ALK Agents in Patients with EML4-ALK-Translocated NSCLC
16:45 - 18:00 | Presenter: Paola Ulivi | Author(s): Matteo Canale, Angelo Delmonte, Claudio Dazzi, Alessandro Gamboni, Maurizio Puccetti, Sara Bravaccini, Claudia Casanova, Maximilian Papi, Marita Mariotti, Nicoletta De Luigi, Gabriele Minuti, Daniele Calistri, Massimiliano Bonafè, Lucio Crinò
- Abstract
Loading... -
+
P2.13-07 - CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Kaihua Lu | Author(s): Meiling Zhang, Qian Wang, Yan Ding, Guoqun Wang, Yunqian Chu, Xiang He, Xue Wu, Yang W. Shao
- Abstract
Loading... -
+
P2.13-09 - Efficacy and Safety of Osimertinib After Prior EGFR TKI: Analysis of Patients Underrepresented in Randomized Clinical Trials
16:45 - 18:00 | Presenter: Luiz H. Araujo | Author(s): Gilberto Castro Jr, Pedro De Marchi, Clarissa Baldotto, Gustavo Werutsky, Giuliano Borges, Clarissa Mathias, Aknar Calabrich, Cassia Costa, Fabio Andre Franke, Ellias Lima, Yeni Neron, Gilberto Schwartsmann, Marcelo Graziano Custodio, Cristiane Sansevero, Helano Carioca Freitas
- Abstract
Loading... -
+
P2.13-10 - Ph I/II Study of Oral Selective AXL Inhibitor Bemcentinib (BGB324) in Combination with Erlotinib in pts with EGFRm NSCLC
16:45 - 18:00 | Presenter: Lauren Byers | Author(s): Kathryn Gold, Julio Peguero, Melissa L. Johnson, Jorge Nieva, Wael A Harb, Alberto A. Chiappori, James Strauss, David E Gerber
- Abstract
Loading... -
+
P2.13-11 - EGFR Amplification and Sensitizing Mutations Correlates with Survival from Erlotinib in Lung Adenocarcinoma Patients (MutP-CLICAP¶)
16:45 - 18:00 | Presenter: Andrés F. Cardona | Author(s): Alejandro Ruiz-Patiño, Christian David Castro, Leonardo Rojas, Oscar Arrieta, Zyanya Lucia Zatarain-Barrón, Hernan Carranza, Carlos Vargas, Jorge Otero, Luis Corrales, Claudio Martin, Rafael Rosell
- Abstract
Loading... -
+
P2.13-12 - The deNovo T790M Mutation Recovered by ddPCR is Associated with a Poor Response to 1st and 2nd Generation EGFR-TKI in Lung Adenocarcinoma.
16:45 - 18:00 | Presenter: Yoon Soo Chang | Author(s): Eun Young Kim, Arum Kim
- Abstract
Loading... -
+
P2.13-13 - Real-World Study of Osimertinib in EGFR T790M-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis
16:45 - 18:00 | Presenter: Parneet Kaur Cheema | Author(s): Geoffrey Liu, Ronald Burkes, Scott Owen, Joanne Yu, Desiree Hao, Jeffrey Rothenstein, Simon Martel, Mussawar Iqbal, Rosalyn Juergens, Wendy Lam, Janessa Laskin
- Abstract
Loading... -
+
P2.13-14 - The Clinical Usefulness of Liquid Biopsy for Detection and Dynamic Monitoring of EGFR T790M in NSCLC Patients on EGFR-TKI Therapy
16:45 - 18:00 | Presenter: Joanna Chorostowska-Wynimko | Author(s): Adam Szpechcinski, Katarzyna Duk, Maciej Bryl, Grzegorz Czyzewicz, Emil Wojda, Mateusz Florczuk, Pawel Sliwinski, Aleksander Barinow-Wojewodzki
- Abstract
Loading... -
+
P2.13-15 - Short-Term Responders of NSCLC to EGFR-TKIs Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms
16:45 - 18:00 | Presenter: Yun Fan | Author(s): Yanjun Xu, Xiaoling Tong, Junrong Yan, Xue Wu, Yang W. Shao
- Abstract
Loading... -
+
P2.13-16 - Preference of Adjuvant Treatments for EGFR-Mutant Resected NSCLC Patients: Results of a National-Wide Survey in China
16:45 - 18:00 | Presenter: Wenhua Liang | Author(s): Minzhang Guo, Weizhe Huang, Yi Zhao, Jianxing He
- Abstract
Loading... -
+
P2.13-17 - Non-Small Cell Lung Cancer in the Very Young: More EGFR/ALK Mutation Rate Than the Elder
16:45 - 18:00 | Presenter: ChienHui He | Author(s): Yuh-Min Chen
- Abstract
Loading... -
+
P2.13-18 - A Multicenter Prospective Biomarker Study to Explore Mechanisms of Afatinib Resistance Based on Digita PCR and Next-Generation Sequencing
16:45 - 18:00 | Presenter: Eiji Iwama | Author(s): Kazuko Sakai, Koichi Azuma, Daijiro Harada, Kaname Nosaki, Katsuyuki Hotta, Makoto Nishio, Takayasu Kurata, Tatsuro Fukuhara, Hiroaki Akamatsu, Koichi Goto, Takayuki Shimose, Junji Kishimoto, Yoichi Nakanishi, Kazuto Nishio, Isamu Okamoto
- Abstract
Loading... -
+
P2.13-19 - Prognostic Value Inferred from the Quantitative Measurement of EGFR Mutation Using PNA-Clamping Method in Advanced EGFR Mutant NSCLC Patients
16:45 - 18:00 | Presenter: Mi-hyun Kim | Author(s): Insu Kim, Jung Seop Eom, Min Ki Lee
- Abstract
Loading... -
+
P2.13-20 - The Comparative Effectiveness of Gefitinib Versus Erlotinib on the Intracranial Progression-Free Survival in Patients with Brain Metastasis
16:45 - 18:00 | Presenter: Yao-Wen Kuo | Author(s): Chou-Han Lin, Chao-Chi Ho
- Abstract
Loading... -
+
P2.13-21 - MET Addiction Can be Circumvented Through EGFR Inhibition Via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLC
16:45 - 18:00 | Presenter: Xue Lin Kwang | Author(s): Dawn Lau, Audrey-Ann Liew, Yuan Ju, Edwin Lim, Gillianne G.Y. Lai, Rahul Nahar, Yvonne Teng, Khi Pin Chua, Jacob Alvarez, Ming Jie Lim, Hui Sun Leong, Fui Teen Chong, Darren Toh, Hong Sheng Quah, Lisda Suteja, Lan Ying Wang, Kiat Hon Lim, Wan-Teck Lim, Eng-Huat Tan, Wei Wei Zhai, Wai Leong Tam, N Gopalakrishna Iyer, Daniel S.W. Tan
- Abstract
Loading... -
+
P2.13-22 - Resistant Patterns to Osimertinib in Non-Small Cell Lung Cancer Patients with Both T790M and Sensitizing EGFR Mutation
16:45 - 18:00 | Presenter: Jae Cheol Lee | Author(s): Sei-Hoon Yang, Dong Kyu Oh
- Abstract
Loading... -
+
P2.13-23 - Osimertinib Treatment Result of Plasma T790M Positive in Different Clinical Failure Modes After First-Line EGFR TKI for EGFR Mutant NSCLC
16:45 - 18:00 | Presenter: Haiyan Li | Author(s): Haihua Yang, Kai Wang, Xiaomai Wu, Feng-Ming Spring Kong, Dongqing Lv
- Abstract
Loading... -
+
P2.13-24 - Prospective Efficacy of Osimertinib in Circulating Tumour DNA (ctDNA) T790M-Mutant NSCLC Patients
16:45 - 18:00 | Presenter: Jordi Remon | Author(s): Cecile Jovelet, Ludovic Lacroix, David Planchard, Laura Mezquita, Karen Howarth, Emma Green, Vincent Plagnol, Clive Morris, Nitzan Rosenfeld, Caroline Caramella, Cecile Lepéchoux, Frank Aboubakar Nana, Angela Botticella, Julien Adam, Roberto Ferrara, Anas Gazzah, Maud Ngocamus1, Jean-Charles Soria, Benjamin Besse
- Abstract
Loading... -
+
P2.13-25 - Analysis of EGFR Mutations Using Circulating Tumour DNA (ctDNA) in Non-Small Cell Lung Cancer Patients in North East Scotland
16:45 - 18:00 | Presenter: Paula Scott | Author(s): Caroline Clark, Keith M Kerr, Tracy Petrie, Marianne Nicolson
- Abstract
Loading... -
+
P2.13-26 - Impact of Concurrent Tumor Suppressor Gene Mutation on Clinical Outcomes in EGFR Mutated NSCLC Treated with First-Line TKI
16:45 - 18:00 | Presenter: Sandhya Sharma | Author(s): Chung-Shien Lee, Emily Miao, Nagashree Seetharamu
- Abstract
Loading... -
+
P2.13-27 - Development, Internal Validation, and Calibration of a Risk Score to Predict Survival in Patients with EGFR Mutant NSCLC
16:45 - 18:00 | Presenter: Ross Soo | Author(s): Isaac Kah Siang Ng, Nesaretnam Barr Kumarakulasinghe, Nicholas Syn
- Abstract
Loading... -
+
P2.13-28 - Comparison of ddPCR and NGS in Liquid Biopsy to Pathology Results in EGFR-Mutated NSCLC
16:45 - 18:00 | Presenter: Christi Marja Johanna Steendam | Author(s): Ron H.N. Van Schaik, Esther Oomen - De Hoop, Peggy N. Atmodimedjo, Evert De Jonge, Jan H. Von Der Thüsen, Winand N.M. Dinjens, Erik Jan Dubbink, Joachim G.J.V. Aerts
- Abstract
Loading... -
+
P2.13-29 - IL-22 Confers Resistance To EGFR-TKIs In Non-Small Cell Lung Cancer Bearing EGFR Gene Mutation and Amplification
16:45 - 18:00 | Presenter: Xiyi Lu | Author(s): Xiaomeng Wang, Jiaqi Yao, Shidai Jin, Renhua Guo
- Abstract
Loading... -
+
P2.13-30 - High-Dose Icotinib in Advanced Non-Small Cell Lung Cancer with EGFR 21 L858R Mutation: The Randomized, Open-Label INCREASE Study
16:45 - 18:00 | Presenter: Shucai Zhang | Author(s): Xi Li, Li Zhang, Jiang Da, Yan Wang, Aimin Zang, Cuimin Ding, Min Zhao, Wuyun Su, Yan Zhang, Diansheng Zhong, Jin Wu, Guangyu An, Cuiying Zhang, Xingsheng Hu, Gang Cheng, Huaqing Wang, Zhihai Han, Xiaohui He, Junli Liu, Li Liang
- Abstract
Loading... -
+
P2.13-31 - p.(Leu747Pro) Mutation Leads to Misdiagnosis in EGFR Mutation Assessment – Analysis in a Cohort of 1841 Polish NSCLC Patients
16:45 - 18:00 | Presenter: Joanna Chorostowska-Wynimko | Author(s): Katarzyna Duk, Paulina Skrońska, Michał Skroński, Aneta Zdral, Dariusz Kowalski, Piotr Rudzinski, Renata Langfort, Tadeusz Orłowski
- Abstract
Loading... -
+
P2.13-32 - TAK-788 is a Novel and Potent Tyrosine Kinase Inhibitor with Selective Activity Against EGFR/HER2
16:45 - 18:00 | Presenter: Jouhara Chouitar | Author(s): Sylvie Vincent, Rachael Brake, Shuanglian Li
- Abstract
Loading... -
+
P2.13-33 - A Case Report of Exceptional Clinical Response to MEK Inhibition in a Patient with NRAS Mutation Positive NSCLC
16:45 - 18:00 | Presenter: Donna Graham | Author(s): Matthew G Krebs, Mahmood Ayub, Jo Dransfield, Hannah Frost, Sreeja Aruketty, Bedirhah Kilerci, Andrew Wallace, Rajender Kamboj, Dhananjay Bakhle, Venkata Palle, Sharad Sharma, Narendra Maharaj, Rajesh Kumawat, Mandar Bhonde, Kristopher Frese, Caroline Dive, Dominic Rothwell, Ged Brady
- Abstract
Loading... -
+
P2.13-34 - Long Intergenic Non-Coding RNA 00665 Induces Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Xiyi Lu | Author(s): Xinyin Liu, Renhua Guo
- Abstract
Loading... -
+
P2.13-35 - Inhibition of H3K27 Demethylation is Toxic in Poorly Differentiated Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Timothy L Lochmann | Author(s): Marissa L Calbert, Krista M Powell, Cyril H Benes, Hisashi Harada, Anthony C Faber
- Abstract
Loading... -
+
P2.13-36 - Analysis of CDK4/6 Pathway Activity in Lung Adenocarcinoma Patients with Oncogenic Driver Mutations in China
16:45 - 18:00 | Presenter: Shun Lu | Author(s): Yongfeng Yu
- Abstract
Loading... -
+
P2.13-37 - Chloroquine overcomes acquired resistance to icotinib in vitro and in vivo through STAT3/STMN1 pathway
16:45 - 18:00 | Presenter: Xin Lyu | Author(s): Lizhong Zeng, Jingyan Yuan, Xia Meng, Ruiying Sun, Boxuan Liu, Ying Bai, Xuan Liu, Zongfang Li, Shuanying Yang
- Abstract
Loading... -
+
P2.13-38 - Impact of Tyrosine Kinase Inhibitor (TKI) Dose on Outcomes of Patients with Lung Cancer
16:45 - 18:00 | Presenter: Emily Miao | Author(s): Stephen Eng, Chung-Shien Lee, Nagashree Seetharamu, Kevin Sullivan
- Abstract
Loading... -
+
P2.13-39 - A Phase Ib Trial of the HSP90 Inhibitor AUY922 in Combination with Pemetrexed in Metastatic Non-Squamous, Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Zorawar Noor | Author(s): Jonathan W. Goldman, William E. Lawler, Diane Melancon, Bijoy Telivala, Fadi Braiteh, Brian A. Dicarlo, Kathleen Kennedy, Diego Martinez, Brad Adams, Xiaoyan Wang, Benjamin Jones, Edward B Garon
- Abstract
Loading... -
+
P2.13-40 - ABP 215 and Bevacizumab in NSCLC Patients: Time Course and Magnitude of Response in the Phase 3 Comparative Trial (MAPLE)
16:45 - 18:00 | Presenter: Valdimir Hanes | Author(s): Nick Thatcher, Jerome Goldschmidt Jr., Michael Thomas, Michael Schenker, Zhiying Pan
- Abstract
Loading... -
+
P2.13-41 - A Novel Mitochondria-Based Targeting to Restore Therapeutic Response in Cisplatin- and Gefitinib-Resistant Human Lung Cancer Cells
16:45 - 18:00 | Presenter: Qinghua Zhou
- Abstract
Loading... -
+
P2.13-42 - Osimertinib Treatment for Patients with EGFR exon 20 Insertion Positive Non-Small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Joop de Langen | Author(s): Bianca Van Veggel, Anthonie Van Der Wekken, Sayed MS Hashemi, Robin Cornelissen, Kim Monkhorst, Danielle Heideman, Teodoa Radonic, Ed MD Schuuring, Egbert F Smit
- Abstract
Loading... -
+
P2.13-43 - Phase 1 Study of the Anti-HER3 Antibody Drug Conjugate U3-1402 in Metastatic or Unresectable EGFR-Mutant NSCLC
16:45 - 18:00 | Presenter: Pasi A Jänne | Author(s): Helena Yu, Melissa L. Johnson, Conor E. Steuer, Michele Vigliotti, Nicole Shipitofsky, Ferdinand Morales Guevara, Shuquan Chen, Channing Yu
- Abstract
Loading... -
+
P2.13-44 - Targeting NFE2L2 Mutations in Advanced Squamous Cell Lung Cancers with the TORC1/2 Inhibitor TAK-228
16:45 - 18:00 | Presenter: Paul K. Paik | Author(s): Linda Ahn, Michelle S Ginsberg, Daniel McFarland, L. Austin Doyle, Charles M. Rudin
- Abstract
Loading... -
+
P2.13-45 - SHERLOC: A Phase 2 Study of Seribantumab in Combination with Docetaxel in Patients with Heregulin Positive, Advanced NSCLC
16:45 - 18:00 | Presenter: Lecia Sequist | Author(s): Pasi A Jänne, Frances A Shepherd, Rudolf M Huber, Jhanelle Elaine Gray, Enriqueta Felip, Maurice Pérol, Fred R. Hirsch, Daniel S.W. Tan, Kim Caliri, Sara Ghassemifar, Ben Wang, Walid Kamoun, Sergio Santillana, Vasileios Askoxylakis, J Marc Pipas
- Abstract
Loading... -
+
P2.13-46 - Comprehensive Investigation of ERBB2 Transmembrane Domain Mutations (V659/G660) in 12,833 Chinese Lung Cancer Patients
16:45 - 18:00 | Presenter: Yang W. Shao | Author(s): Ruoying Yu, Hairong Bao, Sai-Hong Ignatius Ou, Xue Wu
- Abstract
Loading...
-
+
P2.15 - Treatment in the Real World - Support, Survivorship, Systems Research (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.15-01 - CANscript™ as a Patient-Derived Predictive Platform for individualizing Treatment in Lung Cancer
16:45 - 18:00 | Presenter: K Govind Babu | Author(s): Deepak K, Babu Balakrishnan, Manjusha Biswas, Arun Prasath, Padhma Radhakrishnan, Aditi Chatterjee, Saravanan Thyiagarajan, Padmaparna Chaudhury
- Abstract
Loading... -
+
P2.15-02 - Gender-Associated Differences in Patients with Lung Cancer Treated at an Argentinean University Hospital in the Last 10 Years
16:45 - 18:00 | Presenter: Carolina Gabay | Author(s): Mauricio Tournour, Mara Bonet, Aime Giorlando, iris Boyeras, Luis Thompson, Monica Castro
- Abstract
Loading... -
+
P2.15-03 - Availability and Reimbursement of Diagnostic Testing and Novel Anti-Cancer Drugs for NSCLC in CEE: Results of a CECOG Survey
16:45 - 18:00 | Presenter: Luka Brcic | Author(s): Tanja Cufer, Ales Ryska, Tudor Ciuleanu, Christoph Zielinski
- Abstract
Loading... -
+
P2.15-04 - Costs of Cares on the Month Before Death of Patients with Lung Cancer: A French National Database Survey
16:45 - 18:00 | Presenter: Olivier Bylicki | Author(s): Charlène Tournier, florence Canoui-Poitrine, Cecile Blein, Christos Chouaid
- Abstract
Loading... -
+
P2.15-05 - Prescribing Patterns of Physicians and Financial Implications for Lung Cancer Treatment at the End of Life
16:45 - 18:00 | Presenter: Josephine Feliciano | Author(s): Tsz Chan, Bryna Ewachiw, Peng Huang, Lynn Frendak, Julie Waldfogel, Catherine E Burdalski
- Abstract
Loading... -
+
P2.15-06 - Examination of Optimal Timing of Post-Surgical Surveillance for Early Stage Lung Cancer Patients and Association with Outcomes
16:45 - 18:00 | Presenter: Leah Backhus | Author(s): Elizabeth Colwell, Prasha Bhandari, Jalen Benson, Hao He, Natalie Lui, Mark Berry, Joesph Shrager
- Abstract
Loading... -
+
P2.15-07 - Lung Cancer in the Young
16:45 - 18:00 | Presenter: Marco Galvez Nino | Author(s): Rossana Ruiz, Joseph Arturo Pinto, Luis E Raez, Luis Alberto Mas Lopez
- Abstract
Loading... -
+
P2.15-08 - Impact and Feasibility of a Support Group for Women with Lung Cancer
16:45 - 18:00 | Presenter: Paul Wheatley-Price | Author(s): Joanna Gotfrit, Nathalie Daaboul, John Shin, Tinghua Zhang, Diane Manii, Christina Sit
- Abstract
Loading... -
+
P2.15-09 - The Impact of Treatment Evolution in NSCLC (iTEN) Model: Survival and Cost of Treating Patients with Advanced NSCLC in 2017
16:45 - 18:00 | Presenter: Daniel Moldaver | Author(s): Manjusha Hurry, Diana Tran, William Kenneth Evans, Parneet Kaur Cheema, Randeep Sangha, Ronald Burkes, Barbara Melosky, Erik Orava, Daniel Grima
- Abstract
Loading... -
+
P2.15-10 - Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer.
16:45 - 18:00 | Presenter: Badr Id Said | Author(s): Katrina Hueniken, M Catherine Brown, Devalben Patel, Mindy Liang, Catherine Labbe, Lawson Eng, Hiten Naik, Penelope Bradbury, Frances A Shepherd, Natasha B Leighl, Geoffrey Liu, Grainne M O'Kane
- Abstract
Loading... -
+
P2.15-11 - Clinical Outcome of Pulmonary Resection for Non–Small Cell Lung Cancer in Extremely Elderly Patients (85-Year-Old or Over)
16:45 - 18:00 | Presenter: Hiroaki Inoue | Author(s): Kenichi Taguchi, Osamu Kawamata
- Abstract
Loading... -
+
P2.15-12 - Exparel vs. Bupivicaine for Postoperative Analgesia After VATS Lung Resection: Results of a Randomized Control Trial
16:45 - 18:00 | Presenter: Sandeep Khandhar | Author(s): Devon T. Collins, Christy Schatz, Chang Liu, Joby Chandy
- Abstract
Loading... -
+
P2.15-13 - Implementation of a Democratized Approach to Multi-Omic Molecular Profiling Via the LungMATCH Program.
16:45 - 18:00 | Presenter: Jennifer C King | Author(s): R. Joseph Bender, Andrew Ciupek, Achintya Jaitly, Tara Perloff, Kimberly Mason, Subha Madhavan, Emanuel Petricoin
- Abstract
Loading... -
+
P2.15-14 - Survivorship of Advanced Lung Cancer Patients with Psychiatric Disorders and Malnutrition Risk
16:45 - 18:00 | Presenter: Tomi Kovacevic | Author(s): Bojan Zaric, Darijo Bokan
- Abstract
Loading... -
+
P2.15-15 - Differentiating Characteristics of Patients Seeking a Second Opinion: A Survey on Non-Small Cell Lung Cancer Patients
16:45 - 18:00 | Presenter: Sara Hayes | Author(s): Kathryn Volpicelli Leonard, Courtney Robertson, Kaitlyn McNamara
- Abstract
Loading... -
+
P2.15-16 - Clinical Economic Impact of Improved Genotyping in Patients with Advanced Non-Small Cell Lung Adenocarcinoma (NSCLC)
16:45 - 18:00 | Presenter: Victoria M. Raymond | Author(s): Gilberto de Lima Lopes, Jeffrey Scott, Charles Matthews, Shivang Doshi, Elaine Wang, Stan Skrzypczak, Richard B Lanman, David R. Gandara
- Abstract
Loading... -
+
P2.15-17 - Patient Care in Advanced Lung Cancer: Unmet Needs
16:45 - 18:00 | Presenter: Jean-François Morere | Author(s): François Eisinger, Hervé Naman, Rahma Sellami, Christine Lhomel, Gérard Ganem, Jérôme Viguier, Hélène Simon
- Abstract
Loading... -
+
P2.15-18 - Cost-Effectiveness Analysis of Second-Line Immune Checkpoint Inhibitors for Advanced NSCLC in Colombia
16:45 - 18:00 | Presenter: Aylen Vanessa Ospina Serrano | Author(s): Pedro Aguiar Jr, Ricardo Bruges, Jaime Gonzalez Diaz, Auro Del Giglio, Gilberto de Lima Lopes
- Abstract
Loading... -
+
P2.15-19 - Inequality of Access to Novel Lung Cancer Therapies in Europe
16:45 - 18:00 | Presenter: Hazel O'Sullivan | Author(s): Linda Coate
- Abstract
Loading... -
+
P2.15-20 - Educating The Multispecialty Team on Molecular Testing Related to Immunotherapy
16:45 - 18:00 | Presenter: Jeffrey Gregg | Author(s): Tara Perloff, Dan Raz, Lorna Lucas, Pam Rattananont, Wendy Turell, Jennie Crews
- Abstract
Loading... -
+
P2.15-21 - Post Resection Lung Cancer Surveillance: Comparisons of Practice Between STS, ESTS and JACS Members
16:45 - 18:00 | Presenter: Cecilia Pompili | Author(s): Melanie Edwards, Seiki Hasegawa, Ichiro Yoshino, Masayuki Chida, Nuria Novoa, Alessandro Brunelli, Prasha Bhandari, Keith Naunheim, Leah Backhus
- Abstract
Loading... -
+
P2.15-22 - Optimal Glycemic Control Improves Prognosis for Lung Cancer Patients with Diabetes Mellitus
16:45 - 18:00 | Presenter: Baohui Han | Author(s): Jie Qian, Wei Zhang, Xueyan Zhang, Lin Wang, Hua Zhong
- Abstract
Loading... -
+
P2.15-23 - Are there Ethnic Disparities in the Clinical Outcomes of Non-Small Cell Lung Cancer Hispanic Patients Treated with Immunotherapy?
16:45 - 18:00 | Presenter: Luis E Raez | Author(s): Diana Saravia, Teresita Munoz-Antonia, Rossana Ruiz, Doug Cress, Alberto A. Chiappori, Brian Hunis, Daniel Sumarriva, Herman Powery, Luis Alberto Mas Lopez, Gilberto de Lima Lopes, Paola Izquierdo, Scott J Antonia
- Abstract
Loading... -
+
P2.15-24 - Comparison of Pemetrexed Administered q 3 Weeks vs q 4 Weeks as Maintenance Therapy in NSCLC: Analysis of Real World Data from a Single Institution
16:45 - 18:00 | Presenter: Sruthi Kommi Reddy | Author(s): Grace K Dy, Katy Wang, mark Faber, Allison Meagher, Hongbin Chen, Grace K Dy
- Abstract
Loading... -
+
P2.15-25 - NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients
16:45 - 18:00 | Presenter: Delvys Rodríguez-Abreu | Author(s): Juana Campillo, Francisco Grau, Enric Carcereny, Reyes Bernabé, Yolanda Garcia, Angel Artal Cortes, Maria Gonzalez Cao, Oscar Juan, Fernando Garicano, Ignacio Gil-Bazo, Remei Blanco, Monica Guillot, Mariano Provencio, Margarita Majem
- Abstract
Loading... -
+
P2.15-26 - Rates and Economic Burden of Adverse Events in Patients With Metastatic NSCLC Treated with EGFR-TKIs
16:45 - 18:00 | Presenter: Janakiraman Subramanian | Author(s): Francois Laliberté, Ancilla W. Fernandes, Melissa Pavilack, Philippe Jacques, Mei Sheng Duh
- Abstract
Loading... -
+
P2.15-27 - Lung Volume Change After Lobectomy Estimated by Three-Dimensional Image Analysis System
16:45 - 18:00 | Presenter: Hirofumi Suzuki | Author(s): Hiroaki Tsunezuka, Masayoshi Inoue
- Abstract
Loading... -
+
P2.15-28 - Effect of Insurance Types on Tumor Recurrence and Overall Survival in Resectable Non-Small Lung Cancer Patients in Northern Thailand
16:45 - 18:00 | Presenter: Nirush Lertprasertsuke | Author(s): Apichat Tantraworasin, Sophon Siwachat, Emanuela Taioli, Somcharoen Saeteng, Juntima Euathrongchit, Busayamas Chewaskulyong, Sarawut Kongkarnka, Yutthaphan Wannasopha, Thatthan Suksombooncharoen
- Abstract
Loading... -
+
P2.15-29 - Eligibility for Anti-Angiogenic Treatments in Patients with Squamous Non-Small Cell Lung Cancer (SQ-NSCLC): EPISQUAMAB Study (GFPC 2015-01)
16:45 - 18:00 | Presenter: Alain Vergnenegre | Author(s): Victor Basse, Gwenaelle Le Garff, Olivier Bylicki, Catherine Dubos-Arvis, Bénédicte Comet, Marie Marcq, Jacques Le Treut, Jean Bernard Auliac, Anne Madroszyk, Gislaine Fraboulet, Jacky Crequit, Pascal Thomas, Nicolas Paleiron, Isabelle Monnet
- Abstract
Loading... -
+
P2.15-30 - Marital Status and Survival in Patients with Lung Cancer
16:45 - 18:00 | Presenter: Buhai Wang | Author(s): Xuemei Wang
- Abstract
Loading... -
+
P2.15-31 - The Evolution of Costs in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Ontario, Canada Between 1999 to 2014
16:45 - 18:00 | Presenter: Ying Wang | Author(s): Greg R Pond, Amiram Gafni, Hsien Seow, Peter Michael Ellis
- Abstract
Loading... -
+
P2.15-32 - Novice Training : The Time Course for Developing Competence in Single Port Video-Assisted Thoracoscopic Lobectomy
16:45 - 18:00 | Presenter: Ching Feng Wu | Author(s): Marina Paradela, Ching Yang Wu, Diego Gonzalez-Rivas, YinKai Chao
- Abstract
Loading... -
+
P2.15-33 - Evaluation of Liquid Biopsies for Molecular Profiling in Patients (pts) with Advanced NSCLC: What Happens After Panel Testing by NGS?
16:45 - 18:00 | Presenter: Chunxia Su | Author(s): Jing Zhao, Shen Jiqiao, Xuefei Li, Caicun Zhou
- Abstract
Loading...
-
+
P2.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.16-01 - Prognostic Significance of Preoperative Consolidation to Maximum Tumor Diameter Ratio and Suv-Max in Pathological Stage I Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Pınar Akın Kabalak | Author(s): Ülkü Yılmaz, Hakan Ertürk, Özlem Özmen, Şevki Mustafa Demiröz, Derya Kızılgöz, Suna Kavurgacı, Tuba İnal Cengiz
- Abstract
Loading... -
+
P2.16-02 - Predicting Pathological Noninvasiveness in T1 Non-Small Cell Lung Cancer on Chest CT Scan Using Deep Learning Algorithm
16:45 - 18:00 | Presenter: Kyongmin Sarah Beck | Author(s): Sungsoo Park, Ji Hyung Hong, Sae Jung Na, Yoon Ho Ko
- Abstract
Loading... -
+
P2.16-03 - CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC
16:45 - 18:00 | Presenter: Enriqueta Felip | Author(s): Julie R. Brahmer, Stephen Broderick, Scott Swanson, Mark M. Awad, Tetsuya Mitsudomi, Nicolas Girard, Keith M Kerr, Jonathan David Spicer, Junliang Cai, Rong Yang, Patrick M Forde
- Abstract
Loading... -
+
P2.16-04 - Prognostic Value of Lymphovascular Invasion and Its Effect on Patterns of Recurrence in T1-3N0 Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Yeon Sil Kim | Author(s): Ji Hyun Hong, Soo Yoon Sung, Yoo-Kang Kwak, Sea-Won Lee, Jae Kil Park, Kyung Soo Kim, Kyo Young Lee
- Abstract
Loading... -
+
P2.16-05 - Hypermethylation of SOX1, RASSF1A, HOXA9, CDH13 and DAPK Genes Plays a Role in NSCLC Pathogenesis
16:45 - 18:00 | Presenter: Milica Kontic | Author(s): Dragana Jovanovic, Simona Ognjanovic
- Abstract
Loading... -
+
P2.16-06 - Development and Validation of a Gene Expression-Based Nomogram to Predict Relapse in Stage I NSCLC: A Retrospective, Multi-Cohort Study
16:45 - 18:00 | Presenter: Qixing Mao | Author(s): Lin Xu
- Abstract
Loading... -
+
P2.16-07 - Impact of de Novo T790M on Outcome for Resected NSCLC from EGFR Mutant Cohort of Japan Molecular Epidemiology (JME) Study
16:45 - 18:00 | Presenter: Yoshiya Matsumoto | Author(s): Tomoya Kawaguchi, Kenji Sawa, Shun-ichi Isa, Masahiko Ando, Akihiro Tamiya, Akihito Kubo, Hideo Saka, Akihide Matsumura, Yasuhiro Koh
- Abstract
Loading... -
+
P2.16-08 - Influence of Tumour Location and Histological Sub-Type of Non-Small Cell Lung Cancer on Patient Survival
16:45 - 18:00 | Presenter: Alan McWilliam | Author(s): Angela Davey, Eliana Vasquez Osorio, Marianne C Aznar, Corinne Faivre-Finn, Marcel Van Herk
- Abstract
Loading... -
+
P2.16-09 - Patterns of Brain Metastases in Stage I-III Non-Small Cell Lung Cancer: An NCDB Analysis
16:45 - 18:00 | Presenter: Stephanie Renee Rice | Author(s): Melissa Ana Liriano Vyfhuis, Søren M. Bentzen, Surbhi Grover, Charles B. Simone, Pranshu Mohindra
- Abstract
Loading... -
+
P2.16-10 - Prognostic Impact of Postoperative C-Reactive Protein for Non-Small Cell Lung Cancer Following Lobectomy
16:45 - 18:00 | Presenter: Shuichi Shinohara | Author(s): Takamitsu Onitsuka, Masakazu Sugaya
- Abstract
Loading... -
+
P2.16-11 - Prognostic Role of Combined Pulmonary Fibrosis and Emphysema (CPFE) in Patients with Clinical Stage I Lung Cancer.
16:45 - 18:00 | Presenter: Yasuhiro Tsutani | Author(s): Takuro Tasaki, Yoshinori Handa, Daisuke Ueda, Hideaki Hanaki, Yoshihiro Miyata, Morihito Okada
- Abstract
Loading... -
+
P2.16-12 - Expanded Data Confirm Molecular Testing Identifies Lung Adenocarcinoma Patients, Including Stage IA, Who Benefit from Adjuvant Chemotherapy
16:45 - 18:00 | Presenter: Gavitt A. Woodard | Author(s): Sue Wang, Johannes R. Kratz, Greg J. Haro, Matthew A. Gubens, Collin Blakely, Thierry M. Jahan, Kirk D. Jones, Michael J. Mann, David Mark Jablons
- Abstract
Loading... -
+
P2.16-13 - A Proposal of Classification for Subsolid Nodule: Prognostic Impact of T Descriptor
16:45 - 18:00 | Presenter: Erjia Zhu | Author(s): Chang Chen
- Abstract
Loading... -
+
P2.16-14 - Results of Stereotactic Radiation Therapy (SABR) in Early Stage Lung Cancer: Turkish Radiation Oncology Group (TROG) Study
16:45 - 18:00 | Presenter: Banu Atalar | Author(s): Esra Kaytan Sağlam, Züleyha Akgün, Ufuk Abacioglu, Alptekin Arifoglu, Bilgehan Sahin, Enis Ozyar, Gokhan Yaprak, Naciye Ozseker Isik, Hale Basak Caglar Ozkok, Sule Karaman, Sefik Igdem, Ugur Selek, Fazilet Öner Dincbas, Meric Sengoz, Serap Başkaya Yucel, Ayse Nur Demiral, Serap Akyurek
- Abstract
Loading... -
+
P2.16-15 - Toxicities and Survival after Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors
16:45 - 18:00 | Presenter: Banu Atalar | Author(s): Teuta Zoto Mustafayev, Terence Tai Weng Sio, Bilgehan Sahin, Gorkem Gungor, Gokhan Aydin, Bulent Yapici, Enis Ozyar
- Abstract
Loading... -
+
P2.16-16 - SABRTOOTH: A Fasibility Study of SABR Versus Surgery in Patients with Peripheral Stage I NSCLC Considered to be at Higher Risk for Surgery.
16:45 - 18:00 | Presenter: Kevin Franks | Author(s): Lucy McParland, Jo Webster, David Raymond Baldwin, David Sebag-Montefiore, Matthew Evison, Richard Booton, Corinne Faivre-Finn, Babu Naidu, Jonathan Ferguson, Clive Peedell, Matthew Eric Callister, Martyn Kennedy, Walter Gregory, Jenny Hewison, Janine Bestall, Sue Bell, Peter Hall, Michael Snee
- Abstract
Loading... -
+
P2.16-17 - Hypo-Fractionated Accelerated Radiotherapy in Central Early Non-Small Cell Lung Cancer: Leeds Cancer Centre Experience.
16:45 - 18:00 | Presenter: Kevin Franks | Author(s): TANZEEL Janjua, Moses Arunsingh, Katy Louise Clarke, Peter Dickinson, Patrick Murray, Michael Snee, Mark Teo, Pooja Jain
- Abstract
Loading... -
+
P2.16-18 - Study of Interstitial Lung Disease and Acute Exacerbation in Patients Receiving Radiation Therapy for Lung Cancer in Japan.
16:45 - 18:00 | Presenter: Yasuhito Hagiwara | Author(s): Yuko Nakayama, Terufumi Kato, Yoshihiro Saito, Kazushige Hayakawa, Naoki Nakamura, Yoshizumi Kitamoto, Shigeo Takahashi, Kayoko Tsujino, Nobuteru Kubo, Yukihisa Tamaki, Masahiko Kusumoto, Tae Iwasawa, Yasushi Nagata
- Abstract
Loading... -
+
P2.16-19 - Feasibility and Outcomes of Radiofrequency Ablation as Salvage Modality After Hypofractionated Radiation/SBRT for Early NSCLC
16:45 - 18:00 | Presenter: Ritika Harjani Hinduja | Author(s): Jean Seely, Ashish Gupta, Vimoj J Nair, Graham Cook, Robert M. Macrae
- Abstract
Loading... -
+
P2.16-20 - Prognostic Utility of PET in Non-Small Cell Lung Cancer After Empiric Stereotactic Body Radiotherapy (SBRT)
16:45 - 18:00 | Presenter: Shaakir Hasan | Author(s): Rina Petek, David Petrov, Athanasios Colonias, Timothy Mickus, Matthew Van Deusen, Rodney Wegner
- Abstract
Loading... -
+
P2.16-21 - Post-Treatment Survival Difference Between Lobectomy and Stereotactic Ablative Radiotherapy in Stage 1 Non-Small Cell Lung Cancer in England
16:45 - 18:00 | Presenter: Neal Navani | Author(s): Aamir Khakwani, Susan V Harden, Paul Beckett, Richard Hubbard
- Abstract
Loading... -
+
P2.16-22 - Comparing Two Common Radiotherapy Regimens in Non-Small Cell Lung Cancer - A Retrospective Study
16:45 - 18:00 | Presenter: Stephen James Harrow | Author(s): Wai-Yan Poon, Philip McLoone, Yvonne Flanagan, Suzanne Currie, David Keiller
- Abstract
Loading... -
+
P2.16-23 - Focal Therapy for Small Lung Cancer with Ethanol Release Heat-Generating Polymer
16:45 - 18:00 | Presenter: Junichi Shimada | Author(s): Masaaki Shimagaki, Takashi Taniguchi
- Abstract
Loading... -
+
P2.16-24 - Racial Differences in Treatment and Survival of Stage I NSCLC: A Comparison of Veterans Affairs (VA) and SEER-Medicare Populations
16:45 - 18:00 | Presenter: Christina D Williams | Author(s): Naomi Alpert, A. Jasmine Bullard, T.Ivey Redding, Emanuela Taioli
- Abstract
Loading... -
+
P2.16-25 - Lower Hiliar Lymph Node Upstaging in Early NSCLC Vats Surgery is Related to Tumor Location and Does Not Afect Survival
16:45 - 18:00 | Presenter: Marc Boada | Author(s): Rudith Guzman, Mario Montesinos, Alejandra Libreros, Angela Guirao, David Sanchez, Josep Maria Gimferrer, Laureano Molins
- Abstract
Loading... -
+
P2.16-26 - Lung Cancer Resection in Patients with Criteria for Lung Cancer Screening Provides Satisfactory Short Term Results
16:45 - 18:00 | Presenter: David Boulate | Author(s): Sophie Guinard, Alla Bouvier, Sacha Mussot, Delphine Mitilian, Dominique Fabre, Olaf Mercier, Elie Fadel
- Abstract
Loading... -
+
P2.16-27 - Indocyanine Green Virtual Assisted Lung Mapping (ICG-VAL-MAP): Anyone Can Perform a Visible Preoperative Marking Successfully
16:45 - 18:00 | Presenter: Toyofumi Fengshi Chen-Yoshikawa | Author(s): Daisuke Nakajima, Masatsugu Hamaji, Akihiro Ohsumi, Toshi Menju, Toshihiko Sato, Makoto Sonobe, Hiroshi Date
- Abstract
Loading... -
+
P2.16-28 - Comparison of Outcomes of VATS Segmentectomy Versus Lobectomy for Non-Small Cell Lung Cancer Using a Propensity Score Matching Analysis
16:45 - 18:00 | Presenter: Yoohwa Hwang | Author(s): Kwanyong Hyun, Samina Park, Hyun Joo Lee, In Kyu Park, Young Tae Kim, Chang Hyun Kang
- Abstract
Loading... -
+
P2.16-29 - Clinical Outcomes of Surgically Resected Extraabdominal Chest Wall Desmoid Tumors
16:45 - 18:00 | Presenter: Seok Kim | Author(s): Sang-Yun Song, Ju Sik Yun, Kook Joo Na
- Abstract
Loading... -
+
P2.16-30 - Surgical Strategy for Clinical Stage IA Non-Small Cell Lung Cancer Patients with Risk Factors of Pathological Invasion and/or Metastasis
16:45 - 18:00 | Presenter: Terumoto Koike | Author(s): Masaya Nakamura, Yuki Shimizu, Tatsuya Goto, Seijiro Sato, Shin-ichi Toyabe, Masanori Tsuchida
- Abstract
Loading... -
+
P2.16-31 - Examination of the Intersegmental Isolation Method in the Segmental Resection Considering Respiratory Function Preservation
16:45 - 18:00 | Presenter: Katsuo Kojima | Author(s): Makoto Yano, Kenichi Okubo
- Abstract
Loading... -
+
P2.16-32 - Survival Implications and Factors Associated with the Anatomic Level of Incomplete Non-Small-Cell Lung Cancer (NSCLC) Resection
16:45 - 18:00 | Presenter: Yu-Sheng Lee | Author(s): Matthew P Smeltzer, Meredith A Ray, Nicholas R. Faris, Carrie L Fehnel, Cheryl Houston-Harris, Olawale Akinbobola, Philip Ojeabulu, Edward Owen, Richard Eubanks, Hector Dox, David Talton, Horace Lynn Wiggins, Bradley Wolf, Paul Steven Levy, Edward Todd Robbins, Raymond U. Osarogiagbon
- Abstract
Loading... -
+
P2.16-33 - Adenosquamous Carcinoma of the Lung: Comparison of Surgical Outcomes with Squamous Cell and Adenocarcinoma
16:45 - 18:00 | Presenter: Huseyin Melek | Author(s): Gamze Çetinkaya, Ahmet Sami Bayram, Elif U Akyildiz, Eykem Yenturk, Erhan Ozer, Tolga Sevinç, Cengiz Gebitekin
- Abstract
Loading... -
+
P2.16-34 - Visceral Pleural Invasion is Closely Associated with Nodal Spread in cStage IA Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Tetsuya Mizuno | Author(s): Takaaki Arimura, Hiroaki Kuroda, Noriaki Sakakura, Yasushi Yatabe, Yukinori Sakao
- Abstract
Loading... -
+
P2.16-35 - Analysis of Pre and Intra Operative Factors Related to the Operation Time of Lobectomy in VATS: Is the Shape of Thoracic Cavity a Predictive Factor?
16:45 - 18:00 | Presenter: Takuya Nagashima | Author(s): Hiroyuki Ito, Hidehiko Yagasaki, Kenji Inafuku, Junichiro Osawa, Joji Samejima, Nakayama Haruhiko
- Abstract
Loading... -
+
P2.16-36 - Adjuvant Chemotherapy is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Masao Nakata | Author(s): Yuji Nojima, Kei Nanba, Shinsuke Saisho, Katsuhiko Shimizu
- Abstract
Loading... -
+
P2.16-37 - The Introduction of Robotic Lobectomy for Non-Small Cell Lung Cancer in South East Asia: A 5-Year Single Centre Study
16:45 - 18:00 | Presenter: Kingsfield Ong | Author(s): Ali Akbar Fazuludeen, Dokeu Basheer Ahmed Aneez
- Abstract
Loading... -
+
P2.16-38 - Characteristics of Preoperative N Staging in Patients with Optimal Pathologic N Staging of Non Small Cell Lung Cancer(NSCLC)
16:45 - 18:00 | Presenter: Meredith A Ray | Author(s): Matthew P Smeltzer, Nicholas R. Faris, Yu-Sheng Lee, Carrie L Fehnel, Cheryl Houston-Harris, Olawale Akinbobola, Philip Ojeabulu, Edward Owen, Richard Eubanks, Hector Dox, David Talton, Ganpat Valaulikar, Horace Lynn Wiggins, Bradley Wolf, Paul Steven Levy, Edward Todd Robbins, Raymond U. Osarogiagbon
- Abstract
Loading... -
+
P2.16-39 - The Application of 3D Medical Image Analyzer and a Fluorescence Guided Surgery for Pulmonary Sublobar Resection
16:45 - 18:00 | Presenter: Yasuo Sekine | Author(s): Takamasa Itoh, Takahide Toyoda, Daisuke Kaiho, Hidehisa Hoshino, Hodaka Oheda, Eitetsu Koh
- Abstract
Loading... -
+
P2.16-40 - Impact of Preoperative Pectoralis Muscle Quantity and Density on Outcome After Complete Resection of Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Changbo Sun | Author(s): Masaki Anraku, Masaaki Sato, Jun-ichi Nitadori, Kazuhiro Nagayama, Kentaro Kitano, Takahiro Karasaki, Jun Nakajima
- Abstract
Loading... -
+
P2.16-41 - Intraoperative Computed Tomography After Tumor Marking with Metal Clips for Non-Palpable Lung Tumors
16:45 - 18:00 | Presenter: Yoshimasa Tokunaga | Author(s): Sung Soo Chang, Yusuke Kita, Taku Okamoto
- Abstract
Loading... -
+
P2.16-42 - Standard Mediastinoscopy Versus Video-Assisted Mediastinoscopic Lymphadectomy in Clinical N1 Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Akif Turna | Author(s): Huseyin Melek, H.Volkan Kara, Burcu Kilic, Kamil Kaynak
- Abstract
Loading... -
+
P2.16-43 - Diabetes is a Negative Prognostic Factor in Non-Small Cell Lung Cancer Patients Undergoing Resectional Surgery
16:45 - 18:00 | Presenter: Akif Turna | Author(s): Irem Yasar, Esra Şengül, Berat Sozen, H.Volkan Kara, Kamil Kaynak
- Abstract
Loading... -
+
P2.16-44 - Long-Term Outcome of Pulmonary Segmentectomy for c-IA Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Hironobu Wada | Author(s): Takahide Toyoda, Taisuke Kaiho, Kota Ohashi, Yuki Shina, Yuki Sata, Atsushi Hata, Takayoshi Yamamoto, Junichi Morimoto, Yuichi Sakairi, Hidemi Suzuki, Takahiro Nakajima, Ichiro Yoshino
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.16-46 - Clinical Outcomes and Treatment Strategies of Sarcomatoid Carcinoma of the Lung
16:45 - 18:00 | Presenter: Yan Wang
- Abstract
Loading... -
+
P2.16-47 - “Improved aBVA Method” and “Anterior VAB Method” Result in Analogous Survival Benefits During Right Upper Lobectomy
16:45 - 18:00 | Presenter: Jin Xia | Author(s): Wen-Fang Tang, Qiang Nie, Song Dong, Wen-Zhao Zhong
- Abstract
Loading... -
+
P2.16-48 - Outcomes of Stage I Lung Cancer Patients Treated with Segmentectomy via Three-Dimensional Uniportal VATS Versus Two-Dimensional Approach
16:45 - 18:00 | Presenter: Chengliang Yang | Author(s): Yongyu Liu, Wenli Sun, Zhengjun Li, Song Zhang
- Abstract
Loading... -
+
P2.16-49 - Which Nomogram is More Reliable to Predict Recurrence of Pathological Stage IA Lung Adenocarcinoma Treated by Surgery?
16:45 - 18:00 | Presenter: Lu Yang | Author(s): Jun Zhao, Jing Zhang, Fei Xu, Haiyan Xu, Guangjian Yang, Jianming Ying, Yan Wang
- Abstract
Loading... -
+
P2.16-50 - Do Patients Have Preconceived Ideas on Various Surgical Approaches? Patient Perspective: Open vs. Minimally Invasive Surgery (PROMIS) Survey.
16:45 - 18:00 | Presenter: Ching Yeung | Author(s): Andre Martel, Mary Hanna, Ameera Moledina, Andrew J.E. Seely, Donna E Maziak, Farid M Shamji, Sudhir Sundaresan, Patrick James Villeneuve, Sebastian Gilbert
- Abstract
Loading... -
+
P2.16-51 - Nationwide Trends in Surgical Treatment of Lung Cancer in Estonia, 2000−2015
16:45 - 18:00 | Presenter: Tanel Laisaar | Author(s): Liina Lelebina, Bruno Sarana, Indrek Benno, Piret Kibur, Tõnu Vanakesa, Ingemar Almre, Kaja-Triin Laisaar
- Abstract
Loading...
-
+
P2.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.17-01 - Trimodality Therapy (TT) in the Treatment of Stage IIIA Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Tahir Mehmood
- Abstract
Loading... -
+
P2.17-02 - Cardiopulmonary Exercise Tests in Lung Cancer Patients Treated Radical Radiotherapy and Chemotherapy – Feasibility Study
16:45 - 18:00 | Presenter: Nazia Mohammed | Author(s): Richard Jones, Roger Carter, Gillian McVay, Stephen Thomson, Martin Glegg, Claire Lawless, James Paul, Robert Milroy
- Abstract
Loading... -
+
P2.17-03 - A Propensity-Matched Analysis of Neoadjuvant Chemoradiotherapy and Adjuvant Chemoradiotherapy for IIIA(N2) Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Yaping Xu | Author(s): Yaoyao Zhu, Chenxue Jiang, Yun Chen, Jinshi Liu, Qixun Chen, Weimin Mao
- Abstract
Loading... -
+
P2.17-04 - Imiquimod Attenuates Radiation-Induced Pulmonary Fibrosis
16:45 - 18:00 | Presenter: Guler Yavas | Author(s): Mustafa Calik, Esin Celik, Cagdas Yavas, Goknil Calik, Mustafa Fevzi Sargon, Yusuf Tolga Sanli, Hidir Esme, Ozlem Ata
- Abstract
Loading... -
+
P2.17-05 - Consolidation Chemotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer After Concurrent Chemoradiotherapy
16:45 - 18:00 | Presenter: Fatma Basal | Author(s): Ferit Aslan, Güliz Zengin, Umut Demirci, Berna Öksüzoğlu
- Abstract
Loading... -
+
P2.17-06 - Functional Lung Imaging in Radiotherapy for Lung Cancer: A Systematic Review and Meta-Analysis
16:45 - 18:00 | Presenter: Nicholas Wentworth Bucknell | Author(s): Nicholas Hardcastle, Mathias Bressel, Michael S Hofman, Tomas Kron, Shankar Siva
- Abstract
Loading... -
+
P2.17-07 - Concurrent Chemoradiotherapy (ConCRT) using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)
16:45 - 18:00 | Presenter: Haris Charalambous | Author(s): Ifigenia Constantinou, Demetris Vomvas, Nikos Katodritis, George Orphanos, Flora Kyriacou, Ilias Porfiridis, Marios Decatris
- Abstract
Loading... -
+
P2.17-08 - Heart Motion in Lung Radiotherapy: How Representative Are Delineations Based on 3DCT, Average and Maximum Projection Scans?
16:45 - 18:00 | Presenter: David Catharina Petrus Cobben | Author(s): Eliana Vasquez Osorio, Hazel McCallum, Shahid Iqbal, Ahmed Bedair, Alan McWilliam, Gareth Price, John Byrne
- Abstract
Loading... -
+
P2.17-09 - Exploring the Impact of Age on the Efficacy of Adjuvant Chemotherapy After Radical Resection in Non- Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Catherine Joan Davidson | Author(s): Kirsty Taylor, Paula Scullin, Lynn Campbell
- Abstract
Loading... -
+
P2.17-10 - Daily Low–Dose Cisplatin and High Dose Radiotherapy for Elderly Patients with Stage III NSCLC is Well Tolerated.
16:45 - 18:00 | Presenter: E.M.T. Dieleman | Author(s): Rob Van Os, Willemijn Kolff, C.C.E. Koning, J.T. Annema, C.R.N. Rasch
- Abstract
Loading... -
+
P2.17-11 - Impact of Quantitatively Assessed Emphysema on Chest Tube Drainage After Lobectomy for Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Tomasz Gil | Author(s): Zbigniew Grochowski, Janusz Warmus, Krzysztof Bederski, Piotr Kocoń, Janusz Włodarczyk, Łukasz Trybalski, Tomasz Smęder, Katarzyna Żanowska, Piotr Hajder, Bartosz Kołodziejczyk, Wiktor Cieślak, Jarosław Kużdżał, Robert Banyś
- Abstract
Loading... -
+
P2.17-12 - Eliminating Radiation Resistance of Non-Small Cell Lung Cancer By DHA Trough Abrogating Immunity Escaping via Inhibiting PD-L1 Expression
16:45 - 18:00 | Presenter: Xiaomei Gong | Author(s): Xuefei Li, Yaping Xu, Caicun Zhou
- Abstract
Loading... -
+
P2.17-13 - Genome-Wide Copy Number Alterations Profiling Predict Efficacy of Resected Stage II-IIIA Lung Adenocarcinoma
16:45 - 18:00 | Presenter: Xiaohong Han | Author(s): Qiaoyun Tan, Teng Xiong, Sheng Yang, Wumin Dai, Dongmei Lin, Yong Zhou, Hua Lin, Yuankai Shi
- Abstract
Loading... -
+
P2.17-14 - How Should Positive Margin for Bronchial Stumps (R1) Be Evaluated in Patients Undergoing Bronchoplasty for Lung Cancer?
16:45 - 18:00 | Presenter: Kazunori Hata | Author(s): Kenji Suzuki, Aritoshi Hattori, Takeshi Matsunaga, Kazuya Takamochi, Shiaki Oh
- Abstract
Loading... -
+
P2.17-15 - Mediastinoscopic Assessment of N2 Disease and Optimisation of Surgical Treatment of N2 Disease in NSCLC
16:45 - 18:00 | Presenter: George Karimundackal | Author(s): Vijayraj S Patil
- Abstract
Loading... -
+
P2.17-16 - Radical en Bloc Resection for Lung Cancer Invading the Spine
16:45 - 18:00 | Presenter: Masato Kato | Author(s): Sumi Kenji, Mitsuhiko Murakami, Hiroaki Hiramatsu
- Abstract
Loading... -
+
P2.17-17 - Multimodal Treatment in Pathologically Confirmed Single-Station Resectable IIIA-N2 Non-Small Cell Lung Cancer: A Single Center Experience
16:45 - 18:00 | Presenter: Margarita Majem | Author(s): L. Tilea, E. Acosta, Ivana Sullivan, Andrés Barba Joaquín, E. Martínez, J.C. Trujillo, J. Belda, G. Gómez De Segura, J. Craven-Bartle, A. Giménez, V. Camacho, A. Fernández, A. Torrego, V. Pajares, L. López, N. Farré
- Abstract
Loading... -
+
P2.17-18 - A Prognostic Score for Patients Receiving Multimodal Treatment for Locally-Advanced Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Maurice Dantes | Author(s): Julian Taugner, Olarn Roengvoraphoj, Lukas Käsmann, Oleg Petruknov, Kathrin Gennen, Abdo Reem, Chukwuka Eze, Claus Belka, Farkhad Manapov
- Abstract
Loading... -
+
P2.17-19 - Concurrent Chemoradiotherapy with Carboplatin-Paclitaxel Versus Cisplatin-Etoposide for Stage III NSCLC Patients – Review of Literature
16:45 - 18:00 | Presenter: Tahir Mehmood
- Abstract
Loading... -
+
P2.17-20 - Systematic Literature Review of Chemoradiotherapy Versus Radiotherapy Alone in Elderly Patients with Stage III Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Tahir Mehmood
- Abstract
Loading... -
+
P2.17-21 - Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy with 66 Gy for Elderly Patients with Stage III Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Sachiko Miura | Author(s): Kazuya Inoue, Shigeto Hontsu, Hiroaki Tanaka, Masaki Miyauchi, Isao Asakawa, Tetsuro Tamamoto, Masatoshi Hasegawa
- Abstract
Loading... -
+
P2.17-22 - Cardiac Biomarkers in CART Study (CARdiac Toxicity in Lung Cancer Patients After Chemo-Radiotherapy).
16:45 - 18:00 | Presenter: Nazia Mohammed | Author(s): Paul Welsh, Jon Stobo, Stefan Nowicki, Kenneth Mangion, Marimuthu Sankaralingam, Noelle O'Rourke, Martin Glegg, John Foster, Rosie Woodward, James Paul, Claire Lawless, Colin Berry, Naveed Sattar
- Abstract
Loading... -
+
P2.17-23 - Optimal Therapy of Stage III NSCLC: The Role of Surgery in the Era of Immunotherapy
16:45 - 18:00 | Presenter: Sara Moore | Author(s): Cheryl Ho, Bonnie Leung, Jonn Wu
- Abstract
Loading... -
+
P2.17-24 - Does the Change in Body Mass Index During Induction Chemo/Chemoradiotherapy Affect the Outcome of Surgery in Locally Advanced NSCLC?
16:45 - 18:00 | Presenter: Huseyin Melek | Author(s): Erhan Ozer, Gamze Çetinkaya, Adem Deligonul, Tolga Sevinç, Ender Kurt, Ahmet Sami Bayram, Türkkan Evrensel, Cengiz Gebitekin
- Abstract
Loading... -
+
P2.17-25 - Post-Treatment Neutrophil to Lymphocyte Ratio in Locally Advanced NSCLC Patients Treated with Concurrent Chemoradiotherapy
16:45 - 18:00 | Presenter: Eun Young Park | Author(s): Yeon Sil Kim, Yoo-Kang Kwak, Sea-Won Lee, Sook-Hee Hong, Jin-Hyoung Kang, Seung Joon Kim
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.17-27 - IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC with Atezolizumab + Chemotherapy
16:45 - 18:00 | Presenter: Naiyer A Rizvi | Author(s): David R. Gandara, Ben J Solomon, Anthony W. Kim, Alessandro Brunelli, Shawn W. Sun, Barbara J Gitlitz, Kosei Tajima, Wei Lin, Alan Sandler, Solange Peters
- Abstract
Loading... -
+
P2.17-28 - Real-World Data: Survival Outcomes of Chemotherapy Regimens Given Concurrently with Radiotherapy for Locally Advanced NSCLC
16:45 - 18:00 | Presenter: David Chun Cheong Tsui | Author(s): Charles Butts, Sunita Ghosh, Randeep Sangha
- Abstract
Loading... -
+
P2.17-29 - Is Collagen Vascular Disease-Associated Interstitial Lung Disease a High Risk for Lung Cancer Surgery?
16:45 - 18:00 | Presenter: YUKIO Watanabe | Author(s): Mariko Fukui, Takeshi Matsunaga, Kazuya Takamochi, Shiaki Oh, Kenji Suzuki
- Abstract
Loading... -
+
P2.17-30 - Serum Lipoprotein(A) Correlates with the Effect of Endostar Combined with Concurrent Chemoradiotherapy in Patients with Locally Advanced LSCC
16:45 - 18:00 | Presenter: Haihua Yang | Author(s): Miao Wang, Biyun Wang, Xiaomai Wu, Wei Wang, Chao Zhou, Dongqing Lv, Feng-Ming Spring Kong
- Abstract
Loading... -
+
P2.17-31 - The Effect of the Extended Bilateral Mediastinal Lymph Node Dissection Through a Median Sternotomy for Non-Small-Cell Carcinoma of the Left Lung.
16:45 - 18:00 | Presenter: Toshiya Yokota | Author(s): Shingo Ikeda
- Abstract
Loading... -
+
P2.17-32 - Dynamic Monitoring Before and After Neo-Adjuvant Crizotinib in Non-Small Cell Lung Cancer: A Brief Report
16:45 - 18:00 | Presenter: Chao Zhang | Author(s): Ying Chen, Song Dong, Qiang Nie, Jin -Ji Yang, Xue-Ning Yang, Xu-Chao Zhang, Yi-Long Wu, Wen-Zhao Zhong
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
EXH03 - Inivata Exhibit Showcase Session - Liquid Biopsy: Providing Accurate Insights for Advanced NSCLC Patients - A Closer Look at the Validation and Utility of the InVision First - Lung Test (Not IASLC CME Accredited)
- 17:00 - 17:30
- 9/25/2018
- Location: Exhibit Showcase Theater
- Type: Exhibit Showcase
- Track:
-
+
EXH03.01 - Liquid Biopsy - Providing Accurate Insights for Advanced NSCLC Patients - A Closer Look at the Validation and Utility of the InVision FirstTM - Lung Test
17:00 - 17:30 | Presenter: Ramaswamy Govindan, Clive Morris
- Abstract
No abstract available for this presentation